<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="chapter-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><?noissn?><front><journal-meta><journal-id journal-id-type="publisher-id">978-3-319-28797-3</journal-id><journal-id journal-id-type="doi">10.1007/978-3-319-28797-3</journal-id><journal-id journal-id-type="nlm-ta">Transplant Infections</journal-id><journal-title-group><journal-title>Transplant Infections</journal-title><journal-subtitle>Fourth Edition</journal-subtitle></journal-title-group><isbn publication-format="print">978-3-319-28795-9</isbn><isbn publication-format="electronic">978-3-319-28797-3</isbn></journal-meta><article-meta><article-id pub-id-type="pmcid">7122901</article-id><article-id pub-id-type="publisher-id">49</article-id><article-id pub-id-type="doi">10.1007/978-3-319-28797-3_49</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Emerging and Rare Viral Infections in Transplantation</article-title></title-group><contrib-group content-type="book editors"><contrib contrib-type="editor"><name><surname>Ljungman</surname><given-names>Per</given-names></name><address><email>Per.Ljungman@ki.se</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="editor"><name><surname>Snydman</surname><given-names>David</given-names></name><address><email>dsnydman@tuftsmedicalcenter.org</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="editor"><name><surname>Boeckh</surname><given-names>Michael</given-names></name><address><phone>+11+12066676702</phone><email>mboeckh@fhcrc.org</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9241 5705</institution-id><institution-id institution-id-type="GRID">grid.24381.3c</institution-id><institution>Karolinska Institutet, </institution><institution>Karolinska University Hospital, </institution></institution-wrap>Stockholm, Sweden </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7531</institution-id><institution-id institution-id-type="GRID">grid.429997.8</institution-id><institution>Tufts University School of Medicine Tufts Medical Center, </institution></institution-wrap>Boston, Massachusetts USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2180 1622</institution-id><institution-id institution-id-type="GRID">grid.270240.3</institution-id><institution>University of Washington Fred Hutchinson Cancer Research Center, </institution></institution-wrap>Seattle, Washington USA </aff></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Fischer</surname><given-names>Staci A.</given-names></name><degrees>M.D.</degrees><address><email>sfischer@acgme.org</email></address><xref ref-type="aff" rid="Aff4"/></contrib><aff id="Aff4"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9094</institution-id><institution-id institution-id-type="GRID">grid.40263.33</institution-id><institution>Department of Infectious Diseases, </institution><institution>The Warren Alpert Medical School of Brown University, </institution></institution-wrap>470 North Lane, Bristol, RI 02809 USA </aff></contrib-group><pub-date pub-type="epub"><day>15</day><month>02</month><year>2016</year></pub-date><fpage>911</fpage><lpage>924</lpage><permissions><copyright-statement>&#x000a9; Springer International Publishing Switzerland 2016</copyright-statement><license license-type="OpenAccess"><license-p>Open Access This chapter is distributed under the terms of the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Immunocompromised patients such as those undergoing solid organ or hematopoietic stem cell transplantation are at substantial risk for infection with numerous pathogens. Infections with cytomegalovirus (CMV), herpes simplex virus (HSV), Epstein&#x02013;Barr virus (EBV), and human herpesvirus-6 (HHV-6) are well-described complications of transplantation. As viruses previously believed to be quiescent through widespread vaccination (e.g., measles and mumps) reemerge and molecular diagnostic techniques are refined, rare and emerging viral infections are increasingly diagnosed in transplant recipients. This chapter will review the clinical manifestations, diagnosis, and potential antiviral therapies for these viruses in the transplant population.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Bocavirus</kwd><kwd>Coronavirus</kwd><kwd>Hepatitis E</kwd><kwd>Norovirus</kwd><kwd>Parvovirus</kwd><kwd>Metapneumovirus</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer International Publishing Switzerland 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par2">Viral infections are common following solid organ and hematopoietic stem cell transplantation, as detailed in other chapters. While cytomegalovirus (CMV) remains the most prominent virus in transplantation, and the clinical manifestations and complications of infection with other herpesviruses (e.g., herpes simplex virus, Epstein&#x02013;Barr virus, and human herpesviruses 6 and 8) are well described, improvements in diagnostic techniques have led to the recognition of a number of additional viruses with potential pathogenicity in the immunocompromised host. Outbreaks of emerging viruses, the resurgence of vaccine-preventable viral infections, and the identification of viruses which cause self-limited infection in immunocompetent children but significant disease in transplant recipients have highlighted the breadth of pathogens in this patient population. Some of these emerging and unusual viral pathogens are discussed in alphabetical order below.</p><sec id="Sec1"><title>Astrovirus</title><p id="Par3">
Astrovirus is a common cause of viral gastroenteritis throughout the world and has been a cause of outbreaks of diarrheal disease in schools, hospitals, nursing homes, and military bases [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. Several recent reports have highlighted the impact of this RNA virus on immunocompromised hosts. In addition to its role in gastroenteritis in these patients, one astrovirus subgroup (VA1/HMO-C) has been reported to cause encephalitis in allogeneic hematopoietic stem cell transplant (HSCT) recipients and children with X-linked agammaglobulinemia [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Molecular techniques including reverse-transcription polymerase chain reaction (RT-PCR), RNA sequencing, and next-generation sequencing have demonstrated the presence of this subgroup in the cerebrospinal fluid (CSF) and brain tissue of infected patients. Immunohistochemical staining on biopsy tissue has confirmed the presence of invasive infection. There are no known antiviral treatments available, and central nervous system (CNS) infection has been fatal in the cases reported to date. Additional study is needed to determine the prevalence of astrovirus infection in transplanted patients.</p></sec><sec id="Sec2"><title>Bocavirus</title><p id="Par4">
Bocavirus is a human parvovirus that causes upper and lower respiratory tract infection, gastroenteritis, and encephalitis in children [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Infection is most common in the late fall and winter, and most commonly presents with rhinorrhea, fever, cough, wheezing, or diarrhea. Thirty percent of children develop hypoxia, and a variety of radiographic findings have been reported, including peribronchial cuffing, lobar infiltrates, and pleural effusions. Nosocomial infection has occurred [<xref ref-type="bibr" rid="CR8">8</xref>]. Bocavirus infection has been reported in the first few weeks following hematopoietic stem cell transplantation, presenting with fever, rhinorrhea, cough, diarrhea, and hypoxia [<xref ref-type="bibr" rid="CR9">9</xref>]. Virus has been detected in high quantities in plasma, nasopharyngeal aspirates, and stool. Fecal shedding occurs for several weeks to months after clinical resolution of infection [<xref ref-type="bibr" rid="CR10">10</xref>]. Severe and prolonged diarrhea has been described in liver transplant and hematopoietic stem cell recipients [<xref ref-type="bibr" rid="CR11">11</xref>]. It has been suggested that bocavirus, like respiratory syncytial virus (RSV) and parainfluenza, may play a role in the development of bronchiolitis obliterans, a manifestation of chronic rejection in lung transplantation [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. To date, there are no data on antiviral efficacy against bocavirus.</p></sec><sec id="Sec3"><title>Chikungunya Virus</title><p id="Par5">
Chikungunya virus, a mosquito-borne alphavirus transmitted by <italic>Aedes aegypti</italic> and <italic>Aedes albopictus</italic>, is a tropical infection which has caused epidemic disease in India, Thailand, Malaysia, Madagascar, and Reunion Island [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. It is endemic in eastern, central, and southern Africa. In 2013, chikungunya was reported in St. Martin, with epidemic spread throughout the Caribbean, Central America, South America, and Florida, where infection spread locally via <italic>A. aegypti</italic> [<xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par6">After an incubation period of 2&#x02013;4 days, infection presents with high fever, headache, myalgias, and arthralgias, and can resemble dengue. Arthralgias are typically symmetric and involve large joints, particularly in the legs and arms. Frank arthritis may also occur in the interphalangeal joints, wrists, and ankles. Half of patients also develop a rash, which can be maculopapular, petechial, or bullous and is most commonly located on the trunk, with occasional involvement of the face, extremities, palms, and soles. Ocular pain has also been reported. Rarely, meningoencephalitis, myocarditis, or hepatitis can occur. Symptoms resolve in 7&#x02013;10 days, although arthralgias and joint stiffness may persist for weeks to months after fever resolves. Severe manifestations of infection with fatal outcomes have been reported in patients with underlying diabetes, lung disease, or chronic neurologic conditions.</p><p id="Par7">Laboratory findings include lymphopenia, thrombocytopenia, elevated transaminases, and hypocalcemia. Diagnosis may be made serologically or by RT-PCR. IgM antibodies develop as fever resolves, typically 1 week after symptom onset. There is currently no known effective antiviral therapy for chikungunya.</p><p id="Par8">During a widespread outbreak of infection on Reunion Island in the Indian Ocean, organ and tissue donors were screened for the presence of chikungunya infection [<xref ref-type="bibr" rid="CR18">18</xref>]. Corneal donors were found to have serologic and PCR evidence of infection in serum and corneal tissue. Transmission of infection with corneal transplantation is presumed to occur. There have been no reports of transmission of chikungunya in solid organ or stem cell transplantation to date although with reports of infection in Asia, Europe, and North America in travelers from endemic areas, the risk of transmission and the clinical course of infection in these patients require further study.</p></sec><sec id="Sec4"><title>Coronavirus</title><p id="Par9">In February 2003 aworldwide outbreak of severe respiratory infection occurred, infecting more than 8000 patients over several months in 29 countries, most severely affecting southern China, Hong Kong, and Canada, with well-described healthcare-associated outbreaks [<xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>]. Eighty percent of those affected were previously healthy, with no comorbid conditions. The outbreak began in Guangdong Province, China, in November 2002 and with global travel spread rapidly to multiple continents. The infection of numerous health care workers and the rapidly fatal course of infection, even in healthy hosts, were remarkable. Named Severe Acute Respiratory Syndrome (SARS), this infection was quickly determined to be due to a new strain of coronavirus, a group of viruses known to cause human disease since the 1960s [<xref ref-type="bibr" rid="CR27">27</xref>].</p><p id="Par10">Patients initially noted high fever, myalgias, headache, and cough, and subsequently became dyspneic [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. A productive cough was seen in nearly one third of patients, while rash and lymphadenopathy were absent. Lymphopenia, thrombocytopenia, mild elevation of transaminases, prolonged prothrombin time with elevated D-dimers, elevated lactate dehydrogenase (LDH) and creatine kinase (CK), and hyponatremia were common lab findings [<xref ref-type="bibr" rid="CR25">25</xref>]. Chest radiographs revealed focal airspace consolidation or ground glass opacities, initially without the interstitial infiltrates most characteristic of viral pneumonitis, with lower lung field predominance [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Pleural effusions and mediastinal lymphadenopathy were generally absent. Histopathologic findings in lung biopsies and at autopsy included diffuse alveolar damage consistent with adult respiratory distress syndrome (ARDS), with significant alveolar edema, minimal inflammation, and no viral inclusions.</p><p id="Par11">Treatment included corticosteroids and intravenous or oral ribavirin. Although published data are not yet available in humans, animal models suggest that monoclonal antibody to SARS coronavirus (SARS-CoV) is effective in decreasing viral replication and improving outcomes [<xref ref-type="bibr" rid="CR26">26</xref>]. The overall case fatality rate during the SARS epidemic was nearly 10% [<xref ref-type="bibr" rid="CR19">19</xref>]. A novel coronavirus was rapidly isolated and identified as the cause of SARS and sequenced, allowing for RT-PCR and serologic testing to be developed [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>].</p><p id="Par12">During the SARS outbreak in Toronto, a liver transplant recipient was fatally infected while visiting a medical center for an outpatient clinic visit nearly 10 years posttransplant [<xref ref-type="bibr" rid="CR31">31</xref>]. Disseminated infection was described in a lung transplant recipient in whom virus was detected in lungs, bowel, lymph nodes, liver, kidney, skeletal muscle, and brain at autopsy [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Tissue viral loads were significantly higher in transplant recipients than in their immunocompetent counterparts [<xref ref-type="bibr" rid="CR34">34</xref>]. The last of the nearly 8000 reported cases of SARS-CoV was reported in May 2004, after which no additional cases have been reported, for unclear reasons.</p><p id="Par13">In September 2012, initial reports of infection with another novel human coronavirus began in Saudi Arabia, with rapid spread to neighboring Egypt, Iran, Jordan, Kuwait, Lebanon, Qatar, Oman, Yemen, and the United Arab Emirates, then to other continents with airline travel [<xref ref-type="bibr" rid="CR35">35</xref>]. Middle East Respiratory Syndrome Coronavirus (MERS CoV) has been reported to cause severe respiratory tract infection in adult patients, with a mortality rate as high as 60%, most commonly in those with diabetes mellitus and end stage renal disease [<xref ref-type="bibr" rid="CR36">36</xref>]. After a median incubation period of 5 days (range, 2&#x02013;14 days), patients often present with fever, cough, dyspnea, and diarrhea after close contact with an infected case and/or travel from an area where infection is active. Coryza, headache, nausea, vomiting, and abdominal pain have also been reported [<xref ref-type="bibr" rid="CR37">37</xref>]. Laboratory findings include thrombocytopenia, leukopenia, lymphopenia, and elevated transaminases and LDH. Coinfection with other respiratory viruses has been reported [<xref ref-type="bibr" rid="CR38">38</xref>]. As with SARS-CoV, health care workers are at risk for infection [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Dromedary camels have been reported to harbor infection in the Arabian Peninsula, although the mode of transmission of infection has not yet been elucidated [<xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par14">Several cases of MERS CoV infection have been reported in hematopoietic stem cell and solid organ transplant recipients, who have developed bilateral pulmonary infiltrates with respiratory failure, acute renal failure, leukopenia, thrombocytopenia, and elevated transaminases, at times without fever [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR42">42</xref>].</p><p id="Par15">While difficult to grow in cell culture, MERS CoV may be diagnosed by RT-PCR on respiratory secretions. Virus has been detected with these techniques in urine and stool as well. To increase the yield of testing, it is recommended that multiple specimens from different sites (e.g., nasopharyngeal swab, sputum, BAL fluid, serum, and stool) be tested using RT-PCR, which is available from the CDC and local health departments in the USA [<xref ref-type="bibr" rid="CR37">37</xref>]. Due to the risk of transmission of infection to health care workers, contact and airborne precautions are recommended in caring for the suspected MERS-CoV infected patient [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>].</p><p id="Par16">While there have been no randomized, controlled clinical trials of antivirals against MERS-CoV, ribavirin and mycophenolate mofetil (an immunosuppressive agent used commonly in transplantation) have in vitro activity against the virus [<xref ref-type="bibr" rid="CR43">43</xref>]. Ribavirin (in combination with interferon &#x003b1;-2b) has demonstrated promise in decreasing lung injury and viral replication in rhesus macaques infected with MERS-CoV [<xref ref-type="bibr" rid="CR44">44</xref>]. A retrospective cohort study describing the use of ribavirin and interferon &#x003b1;-2a in twenty patients with severe infection demonstrated an early survival benefit [<xref ref-type="bibr" rid="CR45">45</xref>].</p><p id="Par17">Whereas coronaviruses made world headlines with the SARS epidemic in 2002&#x02013;2004 and the MERS-CoV emergence in 2012, coronaviruses OC43 (group 1) and 229E (group 2) have been known for decades to cause upper respiratory tract infections during the fall and winter months. Coronavirus NL63 (group 1) has been reported to cause upper and lower respiratory tract infections in immunocompetent hosts in the Netherlands, and coronavirus HKU1 (group 2) has been reported to cause pneumonia in Hong Kong and France [<xref ref-type="bibr" rid="CR21">21</xref>]. Non-SARS coronaviruses have recently been associated with severe lower respiratory tract infections in hospitalized patients, including lung and liver transplant recipients [<xref ref-type="bibr" rid="CR46">46</xref>]. Coronavirus 229E has been isolated from hematopoietic stem cell transplantation recipients with fever and cough associated with interstitial and alveolar pulmonary infiltrates [<xref ref-type="bibr" rid="CR46">46</xref>]. Pancytopenia may be present. Radiographic infiltrates are most commonly interstitial, although 28% are alveolar. Pleural effusions may be present, and pneumothorax has been noted in a minority of patients. Diagnosis may be made by culture in human hepatoma HUH7 cell line, or by RT-PCR [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>].</p></sec><sec id="Sec5"><title>Hepatitis E</title><p id="Par18">Hepatitis E is endemic in developing countries and has been reported to cause epidemic disease in Asia, Africa, and Latin America via fecal&#x02013;oral transmission [<xref ref-type="bibr" rid="CR48">48</xref>]. Travel-related infection has been reported in those returning from endemic areas with poor sanitation. Recent reports have highlighted the important role of this infection in transplant recipients.</p><p id="Par19">
Hepatitis E virus (HEV) is an RNA virus with four major genotypes with presumed reservoirs in pigs, wild boars, deer, and mollusks [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Seroprevalence surveys indicate that infection in blood donors, even in France and the USA, is significant; in some areas, hepatitis E is more prevalent than hepatitis A [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Epidemics of infection have been described from ingestion of contaminated water, mollusks, and undercooked deer, boar, or pig meat [<xref ref-type="bibr" rid="CR53">53</xref>&#x02013;<xref ref-type="bibr" rid="CR55">55</xref>]. Blood transfusion-transmitted infection has also been described [<xref ref-type="bibr" rid="CR56">56</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>]. After an incubation period of two to nine weeks, patients develop jaundice, abdominal pain, anorexia, and nausea. Fever and chills may occur as well, although rash is unusual. Diagnosis can be made by RT-PCR detection of HEV RNA, which is present between 2 and 6 weeks after infection, as symptoms occur [<xref ref-type="bibr" rid="CR60">60</xref>]. IgM antibodies develop as symptoms resolve, approximately 4 weeks after infection. Elevated transaminases occur, peaking approximately 6 weeks after infection. While viremia resolves within 6 weeks of infection, virus remains detectable in stool for several weeks after viremia resolves and IgG appears. Serum IgG antibodies persist for years after acute infection.</p><p id="Par20">Approximately 10% of patients with acute HEV infection develop fulminant hepatitis with acute hepatic failure; the presence of pregnancy or underlying chronic liver disease (e.g., chronic hepatitis C infection or cirrhosis) increases the risk for severe infection [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Histopathologic findings on liver biopsy include lymphocytic infiltration of portal triads. Chronic hepatitis appears to be rare in immunocompetent hosts.</p><p id="Par21">Disease in organ transplant recipients has been characterized by a high incidence of chronic infection (in up to 60% of acutely infected patients) with progressive fibrosis and eventual cirrhosis [<xref ref-type="bibr" rid="CR63">63</xref>&#x02013;<xref ref-type="bibr" rid="CR66">66</xref>]. Reactivation of infection has been described in liver and allogeneic HSCT recipients, in whom nearly half of infections became chronic [<xref ref-type="bibr" rid="CR67">67</xref>&#x02013;<xref ref-type="bibr" rid="CR69">69</xref>]. Liver transplant recipients appear to be at increased risk for chronic infection resulting from reactivation of HEV after transplantation, as well as acute graft hepatitis from reactivation or primary infection [<xref ref-type="bibr" rid="CR70">70</xref>]. Extrahepatic manifestations of infection in transplant recipients have included glomerulonephritis and neurologic involvement [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR71">71</xref>].</p><p id="Par22">There are no FDA-approved therapies for HEV infection, although decreasing immunosuppression appears to have helped control viremia in some chronically infected transplant recipients. In small studies, interferon alpha and ribavirin have been reported to decrease viremia in these patient populations [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>].</p></sec><sec id="Sec6"><title>Lymphocytic Choriomeningitis Virus</title><p id="Par23">
Lymphocytic choriomeningitis virus (LCMV) gained notoriety as a pathogen in solid organ transplantation in 2005, when the first two outbreaks of donor-transmitted infection were described [<xref ref-type="bibr" rid="CR74">74</xref>&#x02013;<xref ref-type="bibr" rid="CR76">76</xref>]. Additional donor-transmitted outbreaks have recently occurred in the USA and Australia [<xref ref-type="bibr" rid="CR77">77</xref>&#x02013;<xref ref-type="bibr" rid="CR80">80</xref>]. Four clusters of donor-derived infection have occurred in the USA to date.</p><p id="Par24">
LCMV is a rodent-borne Old World arenavirus that causes asymptomatic or mild, self-limited illness in the immunocompetent host. Rodents, especially common house mice, laboratory mice, and hamsters, often acquire infection congenitally, resulting in lifelong, asymptomatic excretion of virus in urine, saliva, and feces [<xref ref-type="bibr" rid="CR81">81</xref>&#x02013;<xref ref-type="bibr" rid="CR84">84</xref>]. Human infection occurs via direct contact with infected rodents or aerosolized infected excreta (e.g., with cleaning soiled cage bedding). Symptoms described in immunocompetent humans include fever, headache, and myalgias, with CSF findings consistent with aseptic meningitis (e.g., lymphocytic pleocytosis). In the normal host, infection is self-limited and carries a mortality rate of less than 1% [<xref ref-type="bibr" rid="CR85">85</xref>].</p><p id="Par25">In the transplant clusters, infection with LCMV has been fatal in more than 80% of cases [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. Patients have presented within the first month posttransplant with fever, diarrhea, abdominal pain, and dyspnea. Rash, headache, lethargy, hypotension, and the presence of pulmonary infiltrates are variable. Thrombocytopenia and anemia have been present, with variable peripheral leukocyte and lymphocyte counts. Acute hepatitis with elevated transaminases has been noted, as well as coagulopathy with prolonged protimes. Patients have developed rapidly progressive multisystem failure with encephalopathy prior to death. In one cluster, while the donor had no evidence of infection in multiple tissues tested, a pet hamster present in the donor&#x02019;s home for several weeks prior to donation was found to have LCMV in multiple tissues [<xref ref-type="bibr" rid="CR74">74</xref>]. Virus isolated from the hamster was identical to that isolated from the infected transplant recipients. The survivor in that cluster, a kidney recipient, was treated with discontinuation of all immune suppression except corticosteroids and with intravenous ribavirin. Similar approaches have been used in more recent cases [<xref ref-type="bibr" rid="CR80">80</xref>].</p><p id="Par26">With four donor-derived infection outbreaks in the USA alone, LCMV infection is likely more common than previously recognized in transplant recipients. Detailed workup of potential organ donors with aseptic meningitis or meningoencephalitis may prevent transmission in some cases. Whether LCMV infection occurs posttransplant in recipients with exposure to pet hamsters or house mice is unknown.</p></sec><sec id="Sec7"><title>Metapneumovirus</title><p id="Par27">Human metapneumovirus is a single-stranded RNA paramyxovirus of worldwide endemicity that causes respiratory tract infection in children, the elderly, and immunocompromised adults, with outbreaks reported in long-term care facilities [<xref ref-type="bibr" rid="CR86">86</xref>&#x02013;<xref ref-type="bibr" rid="CR90">90</xref>]. Infection occurs in the late winter and early spring (January through April), similar to the seasonality of respiratory syncytial virus (RSV). Upper and lower respiratory tract symptoms, including rhinorrhea, sore throat, cough, dyspnea, and fever, have been described.</p><p id="Par28">Infection has been described following lung and heart&#x02013;lung transplantation, resulting in acute pneumonia with diffuse alveolar damage and hyaline membrane formation [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>]. Lung transplant recipients with metapneumovirus pneumonia have a 14% mortality rate and are at higher risk for acute and chronic rejection [<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]. In renal transplant recipients, pneumonitis due to metapneumovirus has been reported 3 years posttransplant [<xref ref-type="bibr" rid="CR94">94</xref>]. In one study of HSCT recipients, human metapneumovirus was isolated via RT-PCR in 26% of symptomatic patients undergoing bronchoscopy and carried a mortality rate of 80% [<xref ref-type="bibr" rid="CR95">95</xref>]. Infection occurred within the first few weeks following transplant, and was characterized by fever, nasal congestion, and cough, with rapid development of hypoxia, hypotension, and progressive pneumonia, with diffuse alveolar hemorrhage in three of five patients [<xref ref-type="bibr" rid="CR94">94</xref>&#x02013;<xref ref-type="bibr" rid="CR96">96</xref>]. Pleural effusions and nodular infiltrates may be seen, which may help differentiate infection from RSV. Coinfection with RSV, rhinovirus, and CMV has been described following lung transplantation [<xref ref-type="bibr" rid="CR97">97</xref>].</p><p id="Par29">Ribavirin has been demonstrated to decrease human metapneumovirus replication in the lungs in a mouse model [<xref ref-type="bibr" rid="CR98">98</xref>], and intravenous ribavirin has been effective in the treatment of several lung transplant recipients with metapneumovirus infection [<xref ref-type="bibr" rid="CR99">99</xref>].</p></sec><sec id="Sec8"><title>Measles</title><p id="Par30">
Measles outbreaks have occurred in multiple states in recent years, with an attack rate of greater than 90% among susceptible patients, including unvaccinated children and adults [<xref ref-type="bibr" rid="CR100">100</xref>&#x02013;<xref ref-type="bibr" rid="CR108">108</xref>]. Affected patients develop fever, cough, and coryza, associated with a characteristic rash. Infection may be complicated by pneumonia, encephalitis, or dissemination, with significant mortality noted in solid organ and HSCT recipients [<xref ref-type="bibr" rid="CR109">109</xref>]. Infection has been associated with waning immunity and is diagnosed serologically. There are no data on antivirals for treatment of measles.</p></sec><sec id="Sec9"><title>Mumps</title><p id="Par31">
Mumps has been increasingly reported in the USA, with more than 10,000 cases reported in a large multistate outbreak in 2005&#x02013;2006 [<xref ref-type="bibr" rid="CR110">110</xref>&#x02013;<xref ref-type="bibr" rid="CR116">116</xref>]. Patients present with acute onset of unilateral or bilateral parotitis; infection may be complicated by orchitis, oophoritis, pancreatitis, mastitis, meningitis, and encephalitis [<xref ref-type="bibr" rid="CR117">117</xref>]. Infection may be diagnosed serologically or via PCR [<xref ref-type="bibr" rid="CR118">118</xref>, <xref ref-type="bibr" rid="CR119">119</xref>]. No antivirals have been investigated in the treatment of mumps. Enhanced efforts at immunization against measles and mumps pretransplant as well as active surveillance posttransplant are warranted.</p><p id="Par32">As a result of the re-emergence of these vaccine-preventable viruses, recent guidelines suggest vaccination with the measles, mumps, and rubella (MMR) vaccine 2 years following hematopoietic stem cell transplantation in patients without evidence of graft-versus-host disease [<xref ref-type="bibr" rid="CR120">120</xref>, <xref ref-type="bibr" rid="CR121">121</xref>]. If at all possible, patients undergoing solid organ transplantation who do not have evidence of protection against measles and mumps (e.g., positive IgG antibody to each) should be vaccinated prior to the initiation of immunosuppressive therapy.</p></sec><sec id="Sec10"><title>Norovirus</title><p id="Par33">
Noroviruses are caliciviruses that cause over 20 million cases of gastroenteritis annually in the USA and over half of all epidemics of gastroenteritis worldwide [<xref ref-type="bibr" rid="CR122">122</xref>&#x02013;<xref ref-type="bibr" rid="CR129">129</xref>]. Infection is acquired via consumption of contaminated foods (including raw oysters, fruit, and vegetables) or via ingestion of or swimming in contaminated water, with spread via fomites and from person to person [<xref ref-type="bibr" rid="CR130">130</xref>&#x02013;<xref ref-type="bibr" rid="CR145">145</xref>]. Infection is extremely contagious and often spreads rapidly as a result of prolonged fecal shedding in affected patients after resolution of symptoms. Outbreaks of infection have been described in multiple settings including military barracks, restaurants, hospitals, long-term care facilities, schools, and cruise ships [<xref ref-type="bibr" rid="CR122">122</xref>].</p><p id="Par34">Infection may be asymptomatic or present with the sudden onset of nausea, vomiting, and diarrhea after an incubation period of less than 48 h. Some studies have suggested that vomiting is more common in children, with diarrheal symptoms predominating in infants and adults [<xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR148">148</xref>]. Infection is most common in the winter months, with symptoms lasting 1&#x02013;7 days [<xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR142">142</xref>, <xref ref-type="bibr" rid="CR148">148</xref>]. Attack rates in some outbreaks have been 50&#x02013;90%, with health care workers at substantial risk for infection [<xref ref-type="bibr" rid="CR127">127</xref>, <xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR137">137</xref>&#x02013;<xref ref-type="bibr" rid="CR139">139</xref>, <xref ref-type="bibr" rid="CR144">144</xref>&#x02013;<xref ref-type="bibr" rid="CR147">147</xref>].</p><p id="Par35">Noroviruses cannot be cultured in vitro, but RT-PCR and enzyme immunoassay (EIA) assays are available for diagnosis in stool specimens [<xref ref-type="bibr" rid="CR148">148</xref>&#x02013;<xref ref-type="bibr" rid="CR150">150</xref>].</p><p id="Par36">Norovirus infection in solid organ transplant recipients is common, and marked by risk for chronic and relapsing infection [<xref ref-type="bibr" rid="CR150">150</xref>]. Infection presents with watery diarrhea, which can cause volume depletion and acute renal failure in renal transplant recipients [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR142">142</xref>, <xref ref-type="bibr" rid="CR149">149</xref>, <xref ref-type="bibr" rid="CR151">151</xref>]. Patients may be symptomatic for months and may shed virus in stool for years. Hematopoietic stem cell transplant recipients have been reported to develop acute and chronic diarrheal disease from norovirus infection, which has been associated with the subsequent development of chronic GVHD [<xref ref-type="bibr" rid="CR151">151</xref>, <xref ref-type="bibr" rid="CR152">152</xref>]. Receipt of cord blood, induction with fludarabine, and receipt of alemtuzumab have been reported to be risk factors for norovirus infection in this setting. Nosocomial outbreaks of infection in HSCT units have resulted in infection of staff and patients, with sepsis from bacterial translocation complicating several cases [<xref ref-type="bibr" rid="CR152">152</xref>, <xref ref-type="bibr" rid="CR153">153</xref>].</p><p id="Par37">Treatment of norovirus infection in transplant recipients has not been investigated in randomized, controlled trials to date. Reduction of immunosuppression resulted in clearance of infection in one intestinal transplant recipient with norovirus infection [<xref ref-type="bibr" rid="CR154">154</xref>]. There are no available antiviral therapies to date. Noroviruses are highly resistant to disinfectants, propagating prolonged transmission in many environments.</p></sec><sec id="Sec11"><title>Parvovirus B19</title><p id="Par38">
Parvovirus B19 infection is common, with 60&#x02013;90% of adults having serologic evidence of prior infection [<xref ref-type="bibr" rid="CR155">155</xref>]. In children, parvovirus infection causes erythema infectiosum, a febrile illness with a characteristic &#x0201c;slapped cheek&#x0201d; rash. Adults with acute parvovirus infection develop a flu-like illness, sometimes with resultant arthropathy. A pathogen of erythroid progenitor cells, parvovirus B19 causes severe anemia in patients with underlying hemolytic disorders and hydrops fetalis in pregnancy. In recent years, neurologic involvement including meningoencephalitis has been described, which may be more common in immunocompromised hosts [<xref ref-type="bibr" rid="CR156">156</xref>, <xref ref-type="bibr" rid="CR157">157</xref>].</p><p id="Par39">In transplant recipients, anemia is the most common presentation of infection. Fever occurs in 25% of patients and arthralgia or rash occurs in less than 10% of those affected [<xref ref-type="bibr" rid="CR158">158</xref>]. Pancytopenia may be present. Other manifestations described in the transplant population include hepatitis, myocarditis, pneumonitis, encephalitis, meningitis, peripheral neuritis, and collapsing glomerulopathy [<xref ref-type="bibr" rid="CR155">155</xref>, <xref ref-type="bibr" rid="CR157">157</xref>&#x02013;<xref ref-type="bibr" rid="CR160">160</xref>]. Those with CNS infection may develop sequelae including seizures, cognitive deficits, stroke, and muscle wasting [<xref ref-type="bibr" rid="CR157">157</xref>]. Donor-transmitted infection has been described, presenting with allograft dysfunction, fever, arthralgia, and pancytopenia, often without a rash [<xref ref-type="bibr" rid="CR161">161</xref>&#x02013;<xref ref-type="bibr" rid="CR164">164</xref>]. Chronic or recurrent anemia may be seen posttransplant, as well as pure red cell aplasia [<xref ref-type="bibr" rid="CR165">165</xref>, <xref ref-type="bibr" rid="CR166">166</xref>]. Parvovirus B19 infection has also been associated with the subsequent development of thrombotic microangiopathy in kidney transplant recipients, including a cluster of cases in Iran; hemophagocytic lymphohistiocytosis has also been described in this population [<xref ref-type="bibr" rid="CR167">167</xref>, <xref ref-type="bibr" rid="CR168">168</xref>]. The significance of the frequent finding of parvovirus DNA in renal allografts pre- and posttransplant is under investigation [<xref ref-type="bibr" rid="CR169">169</xref>]. In other transplant populations, parvovirus may be associated with chronic cellular allograft rejection [<xref ref-type="bibr" rid="CR170">170</xref>].</p><p id="Par40">Diagnosis of parvovirus B19 infection may be made by serology, PCR, or bone marrow examination in immunocompetent hosts. The yield of serologic testing (especially IgM) is limited in transplant recipients who may not mount an adequate antibody response to infection, so that RT-PCR on blood, bone marrow, or other involved tissues is necessary to detect infection in many cases [<xref ref-type="bibr" rid="CR155">155</xref>].</p><p id="Par41">Infection may respond to intravenous immunoglobulin (IVIg), with relapses occurring in up to 25% of immunosuppressed hosts [<xref ref-type="bibr" rid="CR155">155</xref>]. There are no published data on the use of antivirals in parvovirus infection.</p></sec><sec id="Sec12"><title>Polyoma Viruses (KI, WU, and Merkel Cell Carcinoma Polyomaviruses)</title><p id="Par42">Human polyoma viruses such as BK virus and JC virus are well known pathogens in transplantation and are discussed elsewhere. In recent years three additional polyoma viruses have been described as potential pathogens in immunocompromised hosts. Like BK and JC, these viruses frequently cause asymptomatic primary infection in healthy patients and are capable of establishing latent infection which can be reactivated in the setting of immune suppression. KI and WU viruses (named for the institutions in which they were discovered, Karolinska Institutet and Washington University) have been isolated in children with acute respiratory symptoms including wheezing as well as in the setting of pneumonia [<xref ref-type="bibr" rid="CR171">171</xref>, <xref ref-type="bibr" rid="CR172">172</xref>]. Respiratory infection has also been described in HIV-infected patients, in whom higher viral loads have been demonstrated in those with lower CD4 counts [<xref ref-type="bibr" rid="CR173">173</xref>].</p><p id="Par43">KI and WU polyomaviruses have been isolated in nasopharyngeal, sputum, and bronchoalveolar lavage specimens in hematopoietic stem cell and solid organ transplant recipients [<xref ref-type="bibr" rid="CR174">174</xref>, <xref ref-type="bibr" rid="CR175">175</xref>]. These viruses have also been detected in transbronchial biopsy specimens in lung transplant recipients, who in many cases were asymptomatic. Coinfection with other viral and bacterial pathogens has been reported. RT-PCR results should be interpreted with caution in transplant recipients, in whom severe infection has not been described to date. There are no available data on the role of decreasing immunosuppressive therapy or the use of antiviral agents in the development or treatment of infection with KI and WU polyomaviruses.</p><p id="Par44">Merkel cell carcinoma is a neuroendocrine malignancy of the skin which is most common in immunocompromised hosts including transplant recipients [<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR176">176</xref>]. Over 80% of these tumors contain a polyoma virus named Merkel Cell polyomavirus (MCPyV); virus has also been found in respiratory secretions in asymptomatic transplant recipients. Further study of each of these polyomaviruses is ongoing in the transplant population.</p></sec><sec id="Sec13"><title>Rotavirus</title><p id="Par45">
Rotavirus, the most common cause of enteritis worldwide and a common pathogen in healthy children under the age of 3, has become increasingly recognized as a pathogen in pediatric and adult recipients of solid organ transplants [<xref ref-type="bibr" rid="CR177">177</xref>]. Epidemics have occurred through fecal&#x02013;oral transmission, primarily in the winter and spring. Affected patients present with watery diarrhea, nausea, vomiting, abdominal pain, and, in some cases, gastrointestinal bleeding from colonic ulcers. Infection may be diagnosed by antigen detection in stool specimens using ELISA, latex agglutination, or quantitative PCR. Infection is generally self-limited with weaning immunosuppression during the acute phase of illness. There are no published data on antiviral activity against rotavirus; treatment remains symptomatic.</p><p id="Par46">Rotavirus has been associated with a high risk of acute cell-mediated rejection in intestinal transplant recipients, which has been proposed to be related to poor absorption of immunosuppressive agents in the setting of vomiting and diarrhea, as well as immune reactivation of gastrointestinal tract-associated lymphocytes in the setting of infection [<xref ref-type="bibr" rid="CR178">178</xref>]. In HSCT recipients, rotavirus infection may be difficult to differentiate clinically and histopathologically from GVHD.</p><p id="Par47">In 1998, a live, oral, tetravalent rhesus&#x02013;human reassortment rotavirus vaccine (RotaShield, Wyeth-Ayerst Laboratories, St. David, PA) was licensed and recommended for routine immunization of infants in the USA; it was voluntarily withdrawn from the market in 1999 due to its association with intestinal intussusception noted in postmarketing surveillance [<xref ref-type="bibr" rid="CR179">179</xref>&#x02013;<xref ref-type="bibr" rid="CR181">181</xref>]. Two additional Rotavirus vaccines have been studied (RotaTeq, Merck &#x00026; Company, Whitehouse Station, NJ; Rotarix, GlaxoSmithKline Biologicals, Rixensart, Belgium). Both vaccines are oral and contain live virus, and are thus contraindicated in highly immunocompromised patients. Fecal virus shedding has been noted with both vaccines, with transmission of vaccine-associated virus to household members noted with Rotarix [<xref ref-type="bibr" rid="CR181">181</xref>].</p><p id="Par48">Current vaccination guidelines in immunocompromised hosts recommend that HSCT and solid organ transplant recipients not receive this live virus vaccine. Household contacts of patients with immune deficiency may be vaccinated, but the transplant recipient should not change diapers for 4 weeks after vaccination, the usual duration of viral shedding in stool [<xref ref-type="bibr" rid="CR182">182</xref>].</p></sec><sec id="Sec14"><title>West Nile Virus</title><p id="Par49">
West Nile virus (WNV) was initially isolated from a febrile patient in the West Nile Province in Uganda in the 1930s and has been enzootic in Africa, Asia, the Middle East, and parts of the Mediterranean and Europe, causing asymptomatic disease or a self-limited febrile flu-like illness [<xref ref-type="bibr" rid="CR183">183</xref>]. This flavivirus was first detected in the northeastern USA in 1999 and has caused outbreaks of infection in the late summer and early fall throughout the USA since then [<xref ref-type="bibr" rid="CR184">184</xref>, <xref ref-type="bibr" rid="CR185">185</xref>]. Birds are the primary reservoir of infection. Mosquitoes acquire lifelong infection after biting viremic birds, spreading infection from their salivary glands to other species, including humans, with a subsequent bite. In human infection, the incubation period is 2&#x02013;14 days [<xref ref-type="bibr" rid="CR186">186</xref>]. While approximately 80% of infections are asymptomatic, 20% of patients develop West Nile fever, characterized by fever, malaise, anorexia, nausea, myalgias, headache, and occasionally lymphadenopathy [<xref ref-type="bibr" rid="CR187">187</xref>]. One in 150 symptomatic patients develops meningitis and/or encephalitis [<xref ref-type="bibr" rid="CR188">188</xref>]. Meningitis presents with photophobia, phonophobia, meningismus, and hyperreflexia; CSF analysis reveals a lymphocytic pleocytosis (&#x0003c;500 leukocytes/mm<sup>3</sup>, glucose usually normal). Patients with encephalitis develop altered mental status, cranial nerve palsies, seizures, and movement disorders. A minority of patients develop rapid asymmetric weakness that may progress to flaccid paralysis mimicking poliomyelitis, associated with hyporeflexia or areflexia [<xref ref-type="bibr" rid="CR184">184</xref>, <xref ref-type="bibr" rid="CR189">189</xref>, <xref ref-type="bibr" rid="CR190">190</xref>]. Acute neuromuscular respiratory failure may develop, which carries a mortality rate of more than 50% [<xref ref-type="bibr" rid="CR188">188</xref>]. Hemorrhagic fever characteristic of other flaviviruses has also been described [<xref ref-type="bibr" rid="CR191">191</xref>]. The presence of severe weakness and hyporeflexia in a patient with meningoencephalitis should raise the suspicion of WNV infection. MRI may demonstrate meningeal or periventricular enhancement, sometimes mimicking ischemic changes [<xref ref-type="bibr" rid="CR186">186</xref>].</p><p id="Par50">
Transmission of WNVvia dialysis has been suggested [<xref ref-type="bibr" rid="CR192">192</xref>], and transmission via blood transfusion and organ transplantation has been well documented [<xref ref-type="bibr" rid="CR193">193</xref>&#x02013;<xref ref-type="bibr" rid="CR197">197</xref>]. In immunocompromised hosts, central nervous system involvement is common, although CSF pleocytosis may be minimal [<xref ref-type="bibr" rid="CR198">198</xref>&#x02013;<xref ref-type="bibr" rid="CR200">200</xref>]. Community-acquired infection has been reported following solid organ transplantation, occurring 2 months to 10 years posttransplant [<xref ref-type="bibr" rid="CR185">185</xref>, <xref ref-type="bibr" rid="CR199">199</xref>&#x02013;<xref ref-type="bibr" rid="CR202">202</xref>]. A study of WNV infection during an outbreak in Toronto noted that liver, kidney, and heart transplant recipients had 40 times the risk of symptomatic infection as normal hosts [<xref ref-type="bibr" rid="CR203">203</xref>]. In all cases, the recipients had participated in outdoor activities without the use of insect repellant or other personal protective measures. Fever often preceded neurologic symptoms. A delayed serologic response was noted in the transplanted cohort in which infection carried a mortality rate of 25%, versus 9% in the general population. In a Colorado outbreak in 2003, 11 transplant recipients (4 kidney, 2 liver, 2 kidney/pancreas, 1 lung, and 2 HSCT) developed infection requiring hospitalization [<xref ref-type="bibr" rid="CR204">204</xref>]. Ten (91%) developed meningoencephalitis, one developed acute flaccid paralysis without encephalitis, and three patients had meningoencephalitis and paralysis. Two patients died (18% mortality), and three suffered significant neurologic sequelae. It appears that transplant recipients are more likely to develop meningoencephalitis in the setting of acute West Nile virus infection than immunocompetent hosts, perhaps with a higher mortality rate. Prolonged infection can also occur [<xref ref-type="bibr" rid="CR205">205</xref>].</p><p id="Par51">Several cases of WNVinfection have been reported in HSCT recipients [<xref ref-type="bibr" rid="CR206">206</xref>, <xref ref-type="bibr" rid="CR207">207</xref>]. Infection occurred 3&#x02013;5 months posttransplant in the most well-described cases, after engraftment but while on calcineurin inhibitor-based prophylaxis or treatment of chronic graft-versus-host disease. Fever, lethargy, progressive bilateral extremity weakness, and hyporeflexia or areflexia were present. CSF contained 0&#x02013;6 white blood cells/&#x003bc;L; IgG and IgM were negative in CSF and blood in most cases. Diagnosis of WNV infection was made by PCR performed on serum and CSF. All of the described patients died.</p><p id="Par52">
Diagnosisof WNV infection in immunocompetent hosts may be made serologically or via RT-PCR. An IgM antibody capture assay is available and becomes positive in CSF 3&#x02013;5 days after onset of symptoms in nonimmunosuppressed hosts [<xref ref-type="bibr" rid="CR202">202</xref>, <xref ref-type="bibr" rid="CR207">207</xref>], before serum antibody develops; CSF IgG appears approximately 5 days later. Antibody presence may be confirmed with viral neutralization studies. IgM antibodies may persist in serum for up to 12 months after infection resolution, and IgG may persist for years. As in the hematopoietic stem cell recipients noted above, immunocompromised patients demonstrate delayed seroconversion, making diagnosis of acute infection difficult at times. Nucleic acid testing in plasma and/or CSF is the most useful diagnostic test in this setting [<xref ref-type="bibr" rid="CR208">208</xref>].</p><p id="Par53">There are no antiviral agents that have proven efficacy in thetreatment of WNV infection. Ribavirin possesses in vitro activity but demonstrates poor clinical efficacy [<xref ref-type="bibr" rid="CR186">186</xref>, <xref ref-type="bibr" rid="CR209">209</xref>]. IVIg with high titers of anti-WNV antibodies (e.g., from Israel, where infection is endemic) has demonstrated significant clinical benefits in animal models, although antibody titers are low in immune globulin derived from the US donors, which have proven ineffective in treating acute infection [<xref ref-type="bibr" rid="CR184">184</xref>, <xref ref-type="bibr" rid="CR210">210</xref>, <xref ref-type="bibr" rid="CR211">211</xref>]. A report of successful treatment of donor-transmitted WNV infection in a liver transplant recipient by reducing immunosuppression and administering plasma from seropositive blood donors has been published [<xref ref-type="bibr" rid="CR212">212</xref>]. Overall case fatality rates of infection with WNV are 4&#x02013;20% [<xref ref-type="bibr" rid="CR189">189</xref>, <xref ref-type="bibr" rid="CR192">192</xref>], with significantly higher rates in transplant recipients.</p><p id="Par54">Unlike the case in other neuroinvasive viral infections, the severity of initial clinical presentation does not predict theprognosis of WNV infection [<xref ref-type="bibr" rid="CR187">187</xref>, <xref ref-type="bibr" rid="CR190">190</xref>, <xref ref-type="bibr" rid="CR213">213</xref>]. Survivors frequently suffer from prolonged fatigue, myalgias, cognitive deficits, memory loss, and tremors. Parkinsonism, excessive somnolence, and postural instability are reported. Phase I trials of a vaccine have been promising [<xref ref-type="bibr" rid="CR214">214</xref>]. Transplant recipients should be educated about the transmission of West Nile virus and urged to remove any stagnant water collections and to use insect repellant when outdoors at dusk during the later summer and fall in order to prevent infection.</p></sec><sec id="Sec15"><title>Conclusion</title><p id="Par55">Viruses remain the most significant and elusive pathogens infecting patients following solid organ and hematopoietic stem cell transplantation. The days of &#x0201c;it&#x02019;s just a virus&#x0201d; are clearly behind us, as immunosuppression has changed, posttransplant longevity is increasing, and molecular diagnostic methods have dramatically improved [<xref ref-type="bibr" rid="CR215">215</xref>]. Serology may be of limited value in immunocompromised hosts in the diagnosis of acute infection as well as in detecting reactivation of latent infections. Multiplex, quantitative real-time PCR assays are now available to detect multiple viruses, including panels of PCRs for detection of respiratory viruses and CNS pathogens [<xref ref-type="bibr" rid="CR216">216</xref>, <xref ref-type="bibr" rid="CR217">217</xref>]. These sensitive techniques are being evaluated carefully in transplant populations for their specificity and for their potential utility as markers of early infection with surveillance monitoring. The impact of community-acquired respiratory viral infections on the development of acute rejection and bronchiolitis obliterans in lung transplantation appears to be significant and warrants further study [<xref ref-type="bibr" rid="CR218">218</xref>, <xref ref-type="bibr" rid="CR219">219</xref>]. Continued vigilance in detecting emerging viral infections and continued study of potential antiviral therapies in the transplant population will likely improve patient survival.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palombo</surname><given-names>EA</given-names></name><name><surname>Bishop</surname><given-names>RF</given-names></name></person-group><article-title>Annual incidence, serotype distribution, and genetic diversity of human astrovirus isolates from hospitalized children in Melbourne, Australia</article-title><source>J Clin Microbiol</source><year>1996</year><volume>34</volume><fpage>1750</fpage><lpage>3</lpage><?supplied-pmid 8784582?><pub-id pub-id-type="pmid">8784582</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DC</given-names></name><name><surname>Lightfoot</surname><given-names>NF</given-names></name><name><surname>Cubitt</surname><given-names>WD</given-names></name><name><surname>Wilson</surname><given-names>SA</given-names></name></person-group><article-title>Outbreaks of astrovirus type 1 and rotavirus gastroenteritis in a geriatric in-patient population</article-title><source>J Hosp Infect</source><year>1989</year><volume>14</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/0195-6701(89)90128-X</pub-id><?supplied-pmid 2570110?><pub-id pub-id-type="pmid">2570110</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes-Joao</surname><given-names>A</given-names></name><name><surname>Costa</surname><given-names>I</given-names></name><name><surname>Mesquita</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Multiple enteropathogenic viruses in a gastroenteritis outbreak in a military exercise of the Portuguese army</article-title><source>J Clin Virol</source><year>2015</year><volume>68</volume><fpage>73</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2015.05.008</pub-id><?supplied-pmid 26071340?><pub-id pub-id-type="pmid">26071340</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naccache</surname><given-names>SN</given-names></name><name><surname>Peggs</surname><given-names>KS</given-names></name><name><surname>Mattes</surname><given-names>FM</given-names></name><etal/></person-group><article-title>Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing</article-title><source>Clin Infect Dis</source><year>2015</year><volume>60</volume><fpage>919</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1093/cid/ciu912</pub-id><?supplied-pmid 25572898?><pub-id pub-id-type="pmid">25572898</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JR</given-names></name><name><surname>Morfopoulou</surname><given-names>S</given-names></name><name><surname>Hubb</surname><given-names>J</given-names></name><etal/></person-group><article-title>Astrovirus VA1/HMO-C: an increasingly recognized neurotropic pathogen in immunocompromised patients</article-title><source>Clin Infect Dis</source><year>2015</year><volume>60</volume><fpage>881</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/cid/ciu940</pub-id><?supplied-pmid 25572899?><pub-id pub-id-type="pmid">25572899</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kesebir</surname><given-names>D</given-names></name><name><surname>Vazquez</surname><given-names>M</given-names></name><name><surname>Weibel</surname><given-names>C</given-names></name><etal/></person-group><article-title>Human bocavirus infection in young children in the United States: molecular epidemiological profile and clinical characteristics of a newly emerging respiratory virus</article-title><source>J Infect Dis</source><year>2006</year><volume>194</volume><fpage>1276</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1086/508213</pub-id><?supplied-pmid 17041854?><pub-id pub-id-type="pmid">17041854</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>W-X</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>Z-J</given-names></name><etal/></person-group><article-title>Human bocavirus in children hospitalized for acute gastroenteritis: a case&#x02013;control study</article-title><source>Clin Infect Dis</source><year>2008</year><volume>47</volume><fpage>161</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1086/589244</pub-id><pub-id pub-id-type="pmid">18532891</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campe</surname><given-names>H</given-names></name><name><surname>Hartberger</surname><given-names>C</given-names></name><name><surname>Sing</surname><given-names>A</given-names></name></person-group><article-title>Role of human bocavirus infections in outbreaks</article-title><source>J Clin Virol</source><year>2008</year><volume>43</volume><fpage>340</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2008.07.014</pub-id><?supplied-pmid 18835213?><pub-id pub-id-type="pmid">18835213</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitui</surname><given-names>MT</given-names></name><name><surname>Bin Tabib</surname><given-names>SMS</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>Detection of human bocavirus in the cerebrospinal fluid of children with encephalitis</article-title><source>Clin Infect Dis</source><year>2012</year><volume>54</volume><fpage>964</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1093/cid/cir957</pub-id><?supplied-pmid 22238160?><pub-id pub-id-type="pmid">22238160</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manning</surname><given-names>A</given-names></name><name><surname>Russell</surname><given-names>V</given-names></name><name><surname>Eastick</surname><given-names>K</given-names></name><etal/></person-group><article-title>Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses</article-title><source>J Infect Dis</source><year>2006</year><volume>194</volume><fpage>1283</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1086/508219</pub-id><?supplied-pmid 17041855?><pub-id pub-id-type="pmid">17041855</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenk</surname><given-names>T</given-names></name><name><surname>Strahm</surname><given-names>B</given-names></name><name><surname>Kontny</surname><given-names>U</given-names></name><etal/></person-group><article-title>Disseminated bocavirus infection after stem cell transplant</article-title><source>Emerg Infect Dis</source><year>2007</year><volume>13</volume><fpage>1425</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.3201/eid1309.070318</pub-id><?supplied-pmid 18252130?><pub-id pub-id-type="pmid">18252130</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenk</surname><given-names>T</given-names></name><name><surname>Maier</surname><given-names>B</given-names></name><name><surname>Hufnage</surname><given-names>M</given-names></name><etal/></person-group><article-title>Persistence of human bocavirus DNA in immunocompromised children</article-title><source>Pediatr Infect Dis J</source><year>2011</year><volume>30</volume><fpage>82</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1097/INF.0b013e3181f12fcf</pub-id><?supplied-pmid 20736879?><pub-id pub-id-type="pmid">20736879</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyakis</surname><given-names>S</given-names></name><name><surname>van Hal</surname><given-names>SJ</given-names></name><name><surname>Barratt</surname><given-names>J</given-names></name><etal/></person-group><article-title>Absence of human Bocavirus in bronchoalveolar lavage fluid of lung transplant patients</article-title><source>J Clin Virol</source><year>2009</year><volume>44</volume><fpage>179</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2008.10.010</pub-id><?supplied-pmid 19083266?><pub-id pub-id-type="pmid">19083266</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soccal</surname><given-names>PM</given-names></name><name><surname>Aubert</surname><given-names>J-D</given-names></name><name><surname>Bridevaux</surname><given-names>P-O</given-names></name><etal/></person-group><article-title>Upper and lower respiratory tract viral infection and acute graft rejection in lung transplant recipients</article-title><source>Clin Infect Dis</source><year>2010</year><volume>51</volume><fpage>163</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1086/653529</pub-id><?supplied-pmid 20524853?><pub-id pub-id-type="pmid">20524853</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pialoux</surname><given-names>G</given-names></name><name><surname>Gauzere</surname><given-names>B-A</given-names></name><name><surname>Jaureguiberry</surname><given-names>S</given-names></name><name><surname>Strobel</surname><given-names>M</given-names></name></person-group><article-title>Chikungunya, an epidemic arbovirus</article-title><source>Lancet Infect Dis</source><year>2007</year><volume>7</volume><fpage>319</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(07)70107-X</pub-id><?supplied-pmid 17448935?><pub-id pub-id-type="pmid">17448935</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>SC</given-names></name><name><surname>Lecuit</surname><given-names>M</given-names></name></person-group><article-title>Chikungunya virus and the global spread of a mosquito-borne disease</article-title><source>N Engl J Med</source><year>2015</year><volume>372</volume><fpage>1231</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1406035</pub-id><?supplied-pmid 25806915?><pub-id pub-id-type="pmid">25806915</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leparc-Goffart</surname><given-names>I</given-names></name><name><surname>Nougairede</surname><given-names>A</given-names></name><name><surname>Cassadou</surname><given-names>S</given-names></name><etal/></person-group><article-title>Chikungunya in the Americas</article-title><source>Lancet</source><year>2014</year><volume>383</volume><fpage>514</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)60185-9</pub-id><?supplied-pmid 24506907?><pub-id pub-id-type="pmid">24506907</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couderc</surname><given-names>T</given-names></name><name><surname>Gangneux</surname><given-names>N</given-names></name><name><surname>Chretien</surname><given-names>F</given-names></name><etal/></person-group><article-title>Chikungunya virus infection of corneal grafts</article-title><source>J Infect Dis</source><year>2012</year><volume>206</volume><fpage>851</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis296</pub-id><?supplied-pmid 22706183?><pub-id pub-id-type="pmid">22706183</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Revised U.S. surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases&#x02014;United States and worldwide, December 2003. MMWR Morb Mortal Wkly Rep. 2003;52:1202&#x02013;6.</mixed-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Hedley</surname><given-names>AJ</given-names></name><name><surname>Ho</surname><given-names>LM</given-names></name><etal/></person-group><article-title>The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients</article-title><source>Ann Intern Med</source><year>2004</year><volume>141</volume><fpage>662</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-141-9-200411020-00006</pub-id><?supplied-pmid 15520422?><pub-id pub-id-type="pmid">15520422</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vabret</surname><given-names>A</given-names></name><name><surname>Dina</surname><given-names>J</given-names></name><name><surname>Gouarin</surname><given-names>S</given-names></name><etal/></person-group><article-title>Detection of the new human coronavirus HKU1: a report of 6 cases</article-title><source>Clin Infect Dis</source><year>2006</year><volume>42</volume><fpage>634</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1086/500136</pub-id><?supplied-pmid 16447108?><pub-id pub-id-type="pmid">16447108</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>KW</given-names></name><name><surname>Ho</surname><given-names>PL</given-names></name><name><surname>Ooi</surname><given-names>GC</given-names></name><etal/></person-group><article-title>A cluster of cases of severe acute respiratory syndrome in Hong Kong</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>1977</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa030666</pub-id><?supplied-pmid 12671062?><pub-id pub-id-type="pmid">12671062</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Hui</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><etal/></person-group><article-title>A major outbreak of severe acute respiratory syndrome in Hong Kong</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>1986</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa030685</pub-id><?supplied-pmid 12682352?><pub-id pub-id-type="pmid">12682352</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poutanen</surname><given-names>SM</given-names></name><name><surname>Low</surname><given-names>DE</given-names></name><name><surname>Henry</surname><given-names>B</given-names></name><etal/></person-group><article-title>Identification of severe acute respiratory syndrome in Canada</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>1995</fpage><lpage>2005</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa030634</pub-id><?supplied-pmid 12671061?><pub-id pub-id-type="pmid">12671061</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>MP</given-names></name><name><surname>Richardson</surname><given-names>SE</given-names></name><name><surname>McGeer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Early diagnosis of SARS: lessons from the Toronto SARS outbreak</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2006</year><volume>25</volume><fpage>230</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s10096-006-0127-x</pub-id><?supplied-pmid 16586072?><pub-id pub-id-type="pmid">16586072</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>WD</given-names></name><name><surname>Guarner</surname><given-names>J</given-names></name><etal/></person-group><article-title>Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters</article-title><source>J Infect Dis</source><year>2006</year><volume>193</volume><fpage>685</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1086/500143</pub-id><?supplied-pmid 16453264?><pub-id pub-id-type="pmid">16453264</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Gunther</surname><given-names>S</given-names></name><name><surname>Preiser</surname><given-names>W</given-names></name><etal/></person-group><article-title>Identification of a novel coronavirus in patients with severe acute respiratory syndrome</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>1967</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa030747</pub-id><?supplied-pmid 12690091?><pub-id pub-id-type="pmid">12690091</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ksiazek</surname><given-names>TG</given-names></name><name><surname>Erdman</surname><given-names>D</given-names></name><name><surname>Goldsmith</surname><given-names>CS</given-names></name><etal/></person-group><article-title>A novel coronavirus associated with severe acute respiratory syndrome</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>1953</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa030781</pub-id><?supplied-pmid 12690092?><pub-id pub-id-type="pmid">12690092</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>TF</given-names></name><name><surname>Kournikakis</surname><given-names>B</given-names></name><name><surname>Bastien</surname><given-names>N</given-names></name><etal/></person-group><article-title>Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units</article-title><source>J Infect Dis</source><year>2005</year><volume>191</volume><fpage>1472</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1086/429634</pub-id><?supplied-pmid 15809906?><pub-id pub-id-type="pmid">15809906</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>D</given-names></name><name><surname>Johnson</surname><given-names>G</given-names></name><name><surname>Draker</surname><given-names>R</given-names></name><etal/></person-group><article-title>Comprehensive detection and identification of human coronaviruses, including the SARS associated coronavirus, with a single RT-PCR assay</article-title><source>J Virol Methods</source><year>2004</year><volume>122</volume><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2004.07.008</pub-id><?supplied-pmid 15488617?><pub-id pub-id-type="pmid">15488617</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>D</given-names></name><name><surname>Tellier</surname><given-names>R</given-names></name><name><surname>Draker</surname><given-names>R</given-names></name><etal/></person-group><article-title>Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening</article-title><source>Am J Transplant</source><year>2003</year><volume>3</volume><fpage>977</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1034/j.1600-6143.2003.00197.x</pub-id><?supplied-pmid 12859532?><pub-id pub-id-type="pmid">12859532</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farcas</surname><given-names>GA</given-names></name><name><surname>Poutanen</surname><given-names>SM</given-names></name><name><surname>Mazzulli</surname><given-names>T</given-names></name><etal/></person-group><article-title>Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus</article-title><source>J Infect Dis</source><year>2005</year><volume>191</volume><fpage>193</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1086/426870</pub-id><?supplied-pmid 15609228?><pub-id pub-id-type="pmid">15609228</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhing</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Detection of severe acute respiratory syndrome coronavirus in the rain: potential role of the chemokine Mig in pathogenesis</article-title><source>Clin Infect Dis</source><year>2005</year><volume>41</volume><fpage>1089</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1086/444461</pub-id><?supplied-pmid 16163626?><pub-id pub-id-type="pmid">16163626</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svoboda</surname><given-names>T</given-names></name><name><surname>Henry</surname><given-names>B</given-names></name><name><surname>Shulman</surname><given-names>L</given-names></name><etal/></person-group><article-title>Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto</article-title><source>N Engl J Med</source><year>2004</year><volume>350</volume><fpage>2352</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa032111</pub-id><?supplied-pmid 15175437?><pub-id pub-id-type="pmid">15175437</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautret</surname><given-names>P</given-names></name><name><surname>Gray</surname><given-names>GC</given-names></name><name><surname>Charrel</surname><given-names>RN</given-names></name><etal/></person-group><article-title>Emerging viral respiratory tract infections &#x02013; environmental risk factors and transmission</article-title><source>Lancet Infect Dis</source><year>2014</year><volume>14</volume><fpage>1113</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(14)70831-X</pub-id><?supplied-pmid 25189350?><pub-id pub-id-type="pmid">25189350</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Seilmaier</surname><given-names>M</given-names></name><name><surname>Corman</surname><given-names>VM</given-names></name><etal/></person-group><article-title>Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection</article-title><source>Lancet</source><year>2013</year><volume>13</volume><fpage>745</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(13)70154-3</pub-id><?supplied-pmid 23782859?><pub-id pub-id-type="pmid">23782859</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>SA</given-names></name><name><surname>Gerber</surname><given-names>SI</given-names></name><name><surname>Swerdlow</surname><given-names>DL</given-names></name></person-group><article-title>Middle East Respiratory Syndrome Coronavirus: update for clinicians</article-title><source>Clin Infect Dis</source><year>2015</year><volume>60</volume><issue>11</issue><fpage>1686</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1093/cid/civ118</pub-id><?supplied-pmid 25701855?><pub-id pub-id-type="pmid">25701855</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arabi</surname><given-names>YM</given-names></name><name><surname>Arifi</surname><given-names>AA</given-names></name><name><surname>Balkhy</surname><given-names>HH</given-names></name><etal/></person-group><article-title>Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection</article-title><source>Ann Intern Med</source><year>2014</year><volume>160</volume><fpage>389</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.7326/M13-2486</pub-id><?supplied-pmid 24474051?><pub-id pub-id-type="pmid">24474051</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Zumla</surname><given-names>AI</given-names></name><name><surname>Assiri</surname><given-names>A</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus infections in health care workers</article-title><source>N Engl J Med</source><year>2013</year><volume>369</volume><fpage>884</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1308698</pub-id><?supplied-pmid 23923992?><pub-id pub-id-type="pmid">23923992</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Abdallat</surname><given-names>MM</given-names></name><name><surname>Payne</surname><given-names>DC</given-names></name><name><surname>Alqasrawi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Hospital associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description</article-title><source>Clin Infect Dis</source><year>2014</year><volume>59</volume><fpage>1225</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1093/cid/ciu359</pub-id><?supplied-pmid 24829216?><pub-id pub-id-type="pmid">24829216</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Cotton</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>B</given-names></name><etal/></person-group><article-title>Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013</article-title><source>Emerg Infect Dis</source><year>2014</year><volume>20</volume><issue>6</issue><fpage>1012</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.3201/eid2006.140402</pub-id><?supplied-pmid 24857749?><pub-id pub-id-type="pmid">24857749</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>AlGhamdi</surname><given-names>M</given-names></name><name><surname>Mushtaq</surname><given-names>F</given-names></name><name><surname>Awn</surname><given-names>N</given-names></name><name><surname>Shalhoub</surname><given-names>S</given-names></name></person-group><article-title>MERS CoV infection in two renal transplant recipients: case report</article-title><source>Am J Transplant</source><year>2015</year><volume>15</volume><fpage>1101</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1111/ajt.13085</pub-id><?supplied-pmid 25716741?><pub-id pub-id-type="pmid">25716741</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>JFW</given-names></name><name><surname>Chan</surname><given-names>K-H</given-names></name><name><surname>Kao</surname><given-names>RYT</given-names></name><etal/></person-group><article-title>Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus</article-title><source>J Infect</source><year>2013</year><volume>67</volume><fpage>606</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2013.09.029</pub-id><?supplied-pmid 24096239?><pub-id pub-id-type="pmid">24096239</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falzarano</surname><given-names>D</given-names></name><name><surname>de Wit</surname><given-names>E</given-names></name><name><surname>Rasmussen</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Treatment with interferon &#x02013;alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques</article-title><source>Nat Med</source><year>2013</year><volume>19</volume><fpage>1313</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nm.3362</pub-id><?supplied-pmid 24013700?><pub-id pub-id-type="pmid">24013700</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omrani</surname><given-names>AS</given-names></name><name><surname>Saad</surname><given-names>MM</given-names></name><name><surname>Baig</surname><given-names>K</given-names></name><etal/></person-group><article-title>Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study</article-title><source>Lancet Infect Dis</source><year>2014</year><volume>14</volume><fpage>1090</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(14)70920-X</pub-id><?supplied-pmid 25278221?><pub-id pub-id-type="pmid">25278221</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garbino</surname><given-names>J</given-names></name><name><surname>Crespo</surname><given-names>S</given-names></name><name><surname>Aubert</surname><given-names>JD</given-names></name><etal/></person-group><article-title>A prospective hospital based study of the clinical impact of non-severe acute respiratory syndrome (non-SARS)-related human coronavirus infection</article-title><source>Clin Infect Dis</source><year>2006</year><volume>43</volume><fpage>1009</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1086/507898</pub-id><?supplied-pmid 16983613?><pub-id pub-id-type="pmid">16983613</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pene</surname><given-names>F</given-names></name><name><surname>Merlat</surname><given-names>A</given-names></name><name><surname>Vabret</surname><given-names>A</given-names></name></person-group><article-title>Coronavirus 229E-related pneumonia in immunocompromised patients</article-title><source>Clin Infect Dis</source><year>2003</year><volume>37</volume><fpage>929</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1086/377612</pub-id><?supplied-pmid 13130404?><pub-id pub-id-type="pmid">13130404</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname><given-names>HR</given-names></name><name><surname>Bendall</surname><given-names>R</given-names></name><name><surname>Ijaz</surname><given-names>S</given-names></name><name><surname>Banks</surname><given-names>M</given-names></name></person-group><article-title>Hepatitis E: an emerging infection in developed countries</article-title><source>Lancet Infect Dis</source><year>2008</year><volume>8</volume><fpage>698</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(08)70255-X</pub-id><?supplied-pmid 18992406?><pub-id pub-id-type="pmid">18992406</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banks</surname><given-names>M</given-names></name><name><surname>Heath</surname><given-names>GS</given-names></name><name><surname>Grierson</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Evidence for the presence of hepatitis E virus in pigs in the United Kingdom</article-title><source>Vet Rec</source><year>2004</year><volume>154</volume><fpage>223</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1136/vr.154.8.223</pub-id><?supplied-pmid 15005446?><pub-id pub-id-type="pmid">15005446</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YC</given-names></name><name><surname>Zhang</surname><given-names>HY</given-names></name><name><surname>Xia</surname><given-names>NS</given-names></name><etal/></person-group><article-title>Prevalence, isolation and partial sequence analysis of hepatitis E virus from domestic animals in China</article-title><source>J Med Virol</source><year>2002</year><volume>67</volume><fpage>516</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1002/jmv.10131</pub-id><?supplied-pmid 12115997?><pub-id pub-id-type="pmid">12115997</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansuy</surname><given-names>JM</given-names></name><name><surname>Legrand-Abravanel</surname><given-names>F</given-names></name><name><surname>Calot</surname><given-names>JP</given-names></name><etal/></person-group><article-title>High prevalence of anti-hepatitis E virus antibodies in blood donors from south west France</article-title><source>J Med Virol</source><year>2008</year><volume>80</volume><fpage>289</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1002/jmv.21056</pub-id><?supplied-pmid 18098159?><pub-id pub-id-type="pmid">18098159</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>DL</given-names></name><name><surname>Yarbough</surname><given-names>PO</given-names></name><name><surname>Vlahov</surname><given-names>D</given-names></name><etal/></person-group><article-title>Seroreactivity to hepatitis E virus in areas where the disease is not endemic</article-title><source>J Clin Microbiol</source><year>1997</year><volume>35</volume><fpage>1244</fpage><lpage>7</lpage><?supplied-pmid 9114415?><pub-id pub-id-type="pmid">9114415</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Mishiro</surname><given-names>S</given-names></name></person-group><article-title>Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar</article-title><source>J Infect Dis</source><year>2003</year><volume>188</volume><fpage>944</fpage><pub-id pub-id-type="doi">10.1086/378074</pub-id><?supplied-pmid 12964128?><pub-id pub-id-type="pmid">12964128</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tei</surname><given-names>S</given-names></name><name><surname>Kitajima</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Mishiro</surname><given-names>S</given-names></name></person-group><article-title>Zoonotic transmission of hepatitis E virus from deer to human beings</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>371</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(03)14025-1</pub-id><?supplied-pmid 12907011?><pub-id pub-id-type="pmid">12907011</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feagins</surname><given-names>AR</given-names></name><name><surname>Opriessnig</surname><given-names>T</given-names></name><name><surname>Guenette</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Detection and characterization of infectious hepatitis E virus from commercial pig livers sold in local grocery stores in the USA</article-title><source>J Gen Virol</source><year>2007</year><volume>88</volume><fpage>912</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1099/vir.0.82613-0</pub-id><?supplied-pmid 17325364?><pub-id pub-id-type="pmid">17325364</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsui</surname><given-names>T</given-names></name><name><surname>Tsukamoto</surname><given-names>Y</given-names></name><name><surname>Yamazaki</surname><given-names>C</given-names></name><etal/></person-group><article-title>Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion</article-title><source>J Med Virol</source><year>2004</year><volume>74</volume><fpage>563</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1002/jmv.20215</pub-id><?supplied-pmid 15484278?><pub-id pub-id-type="pmid">15484278</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boxall</surname><given-names>E</given-names></name><name><surname>Herborn</surname><given-names>A</given-names></name><name><surname>Kochethu</surname><given-names>G</given-names></name><etal/></person-group><article-title>Transfusion-transmitted hepatitis E in a &#x0201c;nonhyperendemic&#x0201d; country</article-title><source>Transfus Med</source><year>2006</year><volume>16</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3148.2006.00652.x</pub-id><?supplied-pmid 16623913?><pub-id pub-id-type="pmid">16623913</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khuroo</surname><given-names>MS</given-names></name><name><surname>Kamili</surname><given-names>S</given-names></name><name><surname>Yattoo</surname><given-names>GN</given-names></name></person-group><article-title>Hepatitis E infection may be transmitted through blood transfusions in an endemic area</article-title><source>J Gastroenterol Hepatol</source><year>2004</year><volume>19</volume><fpage>778</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1746.2004.03437.x</pub-id><?supplied-pmid 15209625?><pub-id pub-id-type="pmid">15209625</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsubayashi</surname><given-names>K</given-names></name><name><surname>Nagaoka</surname><given-names>Y</given-names></name><name><surname>Sakata</surname><given-names>H</given-names></name><etal/></person-group><article-title>Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan</article-title><source>Transfusion</source><year>2004</year><volume>44</volume><fpage>934</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1111/j.1537-2995.2004.03300.x</pub-id><?supplied-pmid 15157263?><pub-id pub-id-type="pmid">15157263</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayson</surname><given-names>ET</given-names></name><name><surname>Myint</surname><given-names>KS</given-names></name><name><surname>Snitbhan</surname><given-names>R</given-names></name><etal/></person-group><article-title>Viremia, fecal shedding and IgM and IgG responses in patients with hepatitis E</article-title><source>J Infect Dis</source><year>1995</year><volume>172</volume><fpage>927</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1093/infdis/172.4.927</pub-id><?supplied-pmid 7561211?><pub-id pub-id-type="pmid">7561211</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khuroo</surname><given-names>MS</given-names></name><name><surname>Kamili</surname><given-names>S</given-names></name></person-group><article-title>Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy</article-title><source>J Viral Hepat</source><year>2003</year><volume>10</volume><fpage>61</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2893.2003.00398.x</pub-id><?supplied-pmid 12558914?><pub-id pub-id-type="pmid">12558914</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatia</surname><given-names>V</given-names></name><name><surname>Singhal</surname><given-names>A</given-names></name><name><surname>Panda</surname><given-names>SK</given-names></name><name><surname>Acharya</surname><given-names>SK</given-names></name></person-group><article-title>A 20-year single center experience with acute liver failure during pregnancy: is the prognosis really worse?</article-title><source>Hepatology</source><year>2008</year><volume>48</volume><fpage>1577</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1002/hep.22493</pub-id><?supplied-pmid 18925633?><pub-id pub-id-type="pmid">18925633</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halac</surname><given-names>U</given-names></name><name><surname>Beland</surname><given-names>K</given-names></name><name><surname>Lapierre</surname><given-names>P</given-names></name><etal/></person-group><article-title>Chronic hepatitis E in children with liver transplantation</article-title><source>Gut</source><year>2012</year><volume>61</volume><fpage>597</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2011-300708</pub-id><?supplied-pmid 22115826?><pub-id pub-id-type="pmid">22115826</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legrand-Abravanel</surname><given-names>F</given-names></name><name><surname>Kamar</surname><given-names>N</given-names></name><name><surname>Sandres-Saune</surname><given-names>K</given-names></name><etal/></person-group><article-title>Hepatitis E virus infection without reactivation in solid organ transplant recipients, France</article-title><source>Emerg Infect Dis</source><year>2011</year><volume>17</volume><fpage>30</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.3201/eid1701.100527</pub-id><?supplied-pmid 21192851?><pub-id pub-id-type="pmid">21192851</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N</given-names></name><name><surname>Selves</surname><given-names>J</given-names></name><name><surname>Mansuy</surname><given-names>J-M</given-names></name><etal/></person-group><article-title>Hepatitis E virus and chronic hepatitis in solid organ transplant recipients</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>811</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0706992</pub-id><?supplied-pmid 18287603?><pub-id pub-id-type="pmid">18287603</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>leCoutre</surname><given-names>P</given-names></name><name><surname>Meisel</surname><given-names>H</given-names></name><name><surname>Hoffman</surname><given-names>J</given-names></name><etal/></person-group><article-title>Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukemia after allogeneic stem cell transplantation</article-title><source>Gut</source><year>2009</year><volume>58</volume><fpage>699</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1136/gut.2008.165571</pub-id><pub-id pub-id-type="pmid">19359434</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haagsma</surname><given-names>EB</given-names></name><name><surname>Niesters</surname><given-names>HGM</given-names></name><name><surname>van den Berg</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Prevalence of hepatitis E virus infection in liver transplant recipients</article-title><source>Liver Transpl</source><year>2009</year><volume>15</volume><fpage>1225</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/lt.21819</pub-id><?supplied-pmid 19790147?><pub-id pub-id-type="pmid">19790147</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Versluis</surname><given-names>J</given-names></name><name><surname>Pas</surname><given-names>SD</given-names></name><name><surname>Agteresch</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation</article-title><source>Blood</source><year>2013</year><volume>122</volume><fpage>1079</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-03-492363</pub-id><?supplied-pmid 23794068?><pub-id pub-id-type="pmid">23794068</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N</given-names></name><name><surname>Weclawiak</surname><given-names>H</given-names></name><name><surname>Guilbeau-Frugier</surname><given-names>C</given-names></name><etal/></person-group><article-title>Hepatitis E virus and the kidney in solid organ transplant patients</article-title><source>Transplantation</source><year>2012</year><volume>93</volume><fpage>617</fpage><lpage>23</lpage><?supplied-pmid 22298032?><pub-id pub-id-type="pmid">22298032</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pischke</surname><given-names>S</given-names></name><name><surname>Suneetha</surname><given-names>PV</given-names></name><name><surname>Baechlein</surname><given-names>C</given-names></name><etal/></person-group><article-title>Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients</article-title><source>Liver Transpl</source><year>2010</year><volume>16</volume><fpage>74</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1002/lt.21958</pub-id><?supplied-pmid 19866448?><pub-id pub-id-type="pmid">19866448</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N</given-names></name><name><surname>Izopet</surname><given-names>J</given-names></name><name><surname>Cintas</surname><given-names>P</given-names></name><etal/></person-group><article-title>Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis</article-title><source>Am J Transplant</source><year>2010</year><volume>10</volume><fpage>1321</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2010.03068.x</pub-id><?supplied-pmid 20346067?><pub-id pub-id-type="pmid">20346067</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N</given-names></name><name><surname>Rostaing</surname><given-names>L</given-names></name><name><surname>Abravanel</surname><given-names>F</given-names></name><etal/></person-group><article-title>Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation</article-title><source>Clin Infect Dis</source><year>2010</year><volume>50</volume><fpage>e30</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1086/650488</pub-id><?supplied-pmid 20113176?><pub-id pub-id-type="pmid">20113176</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N</given-names></name><name><surname>Rostaing</surname><given-names>L</given-names></name><name><surname>Abravanel</surname><given-names>F</given-names></name><etal/></person-group><article-title>Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection</article-title><source>Gastroenterology</source><year>2010</year><volume>139</volume><fpage>1612</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2010.08.002</pub-id><?supplied-pmid 20708006?><pub-id pub-id-type="pmid">20708006</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>SA</given-names></name><name><surname>Graham</surname><given-names>MB</given-names></name><name><surname>Kuehnert</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Transmission of lymphocytic choriomeningitis virus by organ transplantation</article-title><source>N Engl J Med</source><year>2006</year><volume>354</volume><fpage>2235</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa053240</pub-id><?supplied-pmid 16723615?><pub-id pub-id-type="pmid">16723615</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Lymphocytic choriomeningitis virus infection in organ transplant recipients &#x02013; Massachusetts, Rhode Island, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:537&#x02013;9.</mixed-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paddock</surname><given-names>C</given-names></name><name><surname>Ksiazek</surname><given-names>T</given-names></name><name><surname>Comer</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Pathology of fatal lymphocytic choriomeningitis virus infection in multiple organ transplant recipients from a common donor</article-title><source>Mod Pathol</source><year>2005</year><volume>18</volume><issue>Suppl 1</issue><fpage>263A</fpage></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palacios</surname><given-names>G</given-names></name><name><surname>Druce</surname><given-names>J</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><etal/></person-group><article-title>A new arenavirus in a cluster of fatal transplant-associated diseases</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>991</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa073785</pub-id><?supplied-pmid 18256387?><pub-id pub-id-type="pmid">18256387</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmonds</surname><given-names>P</given-names></name></person-group><article-title>A new arenavirus in transplantation</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>2638</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1056/NEJMc080743</pub-id><?supplied-pmid 18550879?><pub-id pub-id-type="pmid">18550879</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregg</surname><given-names>MB</given-names></name></person-group><article-title>Recent outbreaks of lymphocytic choriomeningitis in the United States of America</article-title><source>Bull World Health Organ</source><year>1975</year><volume>52</volume><fpage>549</fpage><lpage>53</lpage><?supplied-pmid 1085210?><pub-id pub-id-type="pmid">1085210</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacNeil</surname><given-names>A</given-names></name><name><surname>Stoher</surname><given-names>U</given-names></name><name><surname>Farnon</surname><given-names>E</given-names></name><etal/></person-group><article-title>Solid organ transplant-associated lymphocytic choriomeningitis virus, United States, 2011</article-title><source>Emerg Infect Dis</source><year>2012</year><volume>18</volume><fpage>1256</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.3201/eid1808.120212</pub-id><?supplied-pmid 22839997?><pub-id pub-id-type="pmid">22839997</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>MS</given-names></name><name><surname>Moellering</surname><given-names>RC</given-names><suffix>Jr</suffix></name><name><surname>Pope</surname><given-names>HG</given-names></name><etal/></person-group><article-title>Lymphocytic choriomeningitis virus infection traced to a pet hamster</article-title><source>N Engl J Med</source><year>1974</year><volume>291</volume><fpage>610</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1056/NEJM197409192911206</pub-id><?supplied-pmid 4604712?><pub-id pub-id-type="pmid">4604712</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skinner</surname><given-names>HH</given-names></name><name><surname>Knight</surname><given-names>EH</given-names></name></person-group><article-title>The potential role of Syrian hamsters and other small animals as reservoirs of lymphocytic choriomeningitis virus</article-title><source>J Small Anim Pract</source><year>1979</year><volume>20</volume><fpage>145</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1111/j.1748-5827.1979.tb07023.x</pub-id><?supplied-pmid 423535?><pub-id pub-id-type="pmid">423535</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Childs</surname><given-names>JE</given-names></name><name><surname>Glass</surname><given-names>GE</given-names></name><name><surname>Ksiazek</surname><given-names>TG</given-names></name><etal/></person-group><article-title>Human-rodent contact and infection with lymphocytic choriomeningitis and Seoul viruses in an inner city population</article-title><source>Am J Trop Med Hyg</source><year>1991</year><volume>44</volume><fpage>117</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1991.44.117</pub-id><?supplied-pmid 1672798?><pub-id pub-id-type="pmid">1672798</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amman</surname><given-names>BR</given-names></name><name><surname>Pavlin</surname><given-names>BI</given-names></name><name><surname>Albarino</surname><given-names>CG</given-names></name><etal/></person-group><article-title>Pet rodents and fatal lymphocytic choriomeningitis in transplant patients</article-title><source>Emerg Infect Dis</source><year>2007</year><volume>13</volume><fpage>719</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.3201/eid1305.061269</pub-id><?supplied-pmid 17553250?><pub-id pub-id-type="pmid">17553250</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warkel</surname><given-names>RL</given-names></name><name><surname>Rinaldi</surname><given-names>CF</given-names></name><name><surname>Bancroft</surname><given-names>WH</given-names></name><etal/></person-group><article-title>Fatal acute meningoencephalitis due to lymphocytic choriomeningitis virus</article-title><source>Neurology</source><year>1973</year><volume>23</volume><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1212/WNL.23.2.198</pub-id><?supplied-pmid 4568992?><pub-id pub-id-type="pmid">4568992</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dare</surname><given-names>R</given-names></name><name><surname>Sanghavi</surname><given-names>S</given-names></name><name><surname>Bullotta</surname><given-names>A</given-names></name><etal/></person-group><article-title>Diagnosis of human metapneumovirus infection in immunocompromised lung transplant recipients and children evaluated for pertussis</article-title><source>J Clin Microbiol</source><year>2007</year><volume>45</volume><fpage>548</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1128/JCM.01621-06</pub-id><?supplied-pmid 17065270?><pub-id pub-id-type="pmid">17065270</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esper</surname><given-names>F</given-names></name><name><surname>Boucher</surname><given-names>D</given-names></name><name><surname>Weibel</surname><given-names>C</given-names></name><etal/></person-group><article-title>Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children</article-title><source>Pediatrics</source><year>2003</year><volume>111</volume><fpage>1407</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1542/peds.111.6.1407</pub-id><?supplied-pmid 12777560?><pub-id pub-id-type="pmid">12777560</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastien</surname><given-names>N</given-names></name><name><surname>Ward</surname><given-names>D</given-names></name><name><surname>Van Caeseele</surname><given-names>P</given-names></name><etal/></person-group><article-title>Human metapneumovirus infection in the Canadian population</article-title><source>J Clin Microbiol</source><year>2003</year><volume>41</volume><fpage>4642</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1128/JCM.41.10.4642-4646.2003</pub-id><?supplied-pmid 14532196?><pub-id pub-id-type="pmid">14532196</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esper</surname><given-names>F</given-names></name><name><surname>Martinello</surname><given-names>RA</given-names></name><name><surname>Boucher</surname><given-names>D</given-names></name><etal/></person-group><article-title>A 1-year experience with human metapneumovirus in children aged &#x0003c;5 years</article-title><source>J Infect Dis</source><year>2004</year><volume>189</volume><fpage>1388</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1086/382482</pub-id><?supplied-pmid 15073675?><pub-id pub-id-type="pmid">15073675</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boivin</surname><given-names>G</given-names></name><name><surname>De Serres</surname><given-names>G</given-names></name><name><surname>Hamelin</surname><given-names>ME</given-names></name><etal/></person-group><article-title>An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility</article-title><source>Clin Infect Dis</source><year>2007</year><volume>44</volume><fpage>1152</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1086/513204</pub-id><?supplied-pmid 17407031?><pub-id pub-id-type="pmid">17407031</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumino</surname><given-names>KC</given-names></name><name><surname>Agapov</surname><given-names>E</given-names></name><name><surname>Pierce</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment</article-title><source>J Infect Dis</source><year>2005</year><volume>192</volume><fpage>1052</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1086/432728</pub-id><?supplied-pmid 16107959?><pub-id pub-id-type="pmid">16107959</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larcher</surname><given-names>C</given-names></name><name><surname>Geltner</surname><given-names>C</given-names></name><name><surname>Fischer</surname><given-names>H</given-names></name><etal/></person-group><article-title>Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology</article-title><source>J Heart Lung Transplant</source><year>2005</year><volume>24</volume><fpage>1891</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1016/j.healun.2005.02.014</pub-id><?supplied-pmid 16297797?><pub-id pub-id-type="pmid">16297797</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dosanjh</surname><given-names>A</given-names></name></person-group><article-title>Respiratory metapneumovirus infection without co-infection in association with acute and chronic lung allograft dysfunction</article-title><source>J Inflamm Res</source><year>2015</year><volume>8</volume><fpage>79</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.2147/JIR.S78259</pub-id><?supplied-pmid 25848314?><pub-id pub-id-type="pmid">25848314</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>A</given-names></name><name><surname>Chuen</surname><given-names>JN</given-names></name><name><surname>Taylor</surname><given-names>C</given-names></name><etal/></person-group><article-title>Acute respiratory infection in a renal transplant recipient</article-title><source>Nephrol Dial Transplant</source><year>2005</year><volume>20</volume><fpage>2848</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfi167</pub-id><?supplied-pmid 16221714?><pub-id pub-id-type="pmid">16221714</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Englund</surname><given-names>JA</given-names></name><name><surname>Boeckh</surname><given-names>M</given-names></name><name><surname>Kuypers</surname><given-names>J</given-names></name><etal/></person-group><article-title>Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients</article-title><source>Ann Intern Med</source><year>2006</year><volume>144</volume><fpage>344</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-144-5-200603070-00010</pub-id><?supplied-pmid 16520475?><pub-id pub-id-type="pmid">16520475</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debiaggi</surname><given-names>M</given-names></name><name><surname>Canducci</surname><given-names>F</given-names></name><name><surname>Sampaolo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients</article-title><source>J Infect Dis</source><year>2006</year><volume>194</volume><fpage>474</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1086/505881</pub-id><?supplied-pmid 16845630?><pub-id pub-id-type="pmid">16845630</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerna</surname><given-names>G</given-names></name><name><surname>Vitulo</surname><given-names>P</given-names></name><name><surname>Rovida</surname><given-names>F</given-names></name><etal/></person-group><article-title>Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients</article-title><source>J Med Virol</source><year>2006</year><volume>78</volume><fpage>408</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/jmv.20555</pub-id><?supplied-pmid 16419110?><pub-id pub-id-type="pmid">16419110</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamlin</surname><given-names>ME</given-names></name><name><surname>Prince</surname><given-names>GA</given-names></name><name><surname>Boivin</surname><given-names>G</given-names></name></person-group><article-title>Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection</article-title><source>Antimicrob Agents Chemother</source><year>2006</year><volume>50</volume><fpage>774</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1128/AAC.50.2.774-777.2006</pub-id><pub-id pub-id-type="pmid">16436743</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raza</surname><given-names>K</given-names></name><name><surname>Ismailjee</surname><given-names>SB</given-names></name><name><surname>Crespo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin</article-title><source>J Heart Lung Transplant</source><year>2007</year><volume>26</volume><fpage>862</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.healun.2007.05.020</pub-id><?supplied-pmid 17692793?><pub-id pub-id-type="pmid">17692793</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Import associated measles outbreak-Indiana, May&#x02013;June 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1073&#x02013;75.</mixed-citation></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Measles among adults associated with adoption of children in China&#x02014;California, Missouri, and Washington, July&#x02013;August 2006. MMWR Morb Mortal Wkly Rep. 2007;56:144&#x02013;6.</mixed-citation></ref><ref id="CR102"><label>102.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Multistate measles outbreak associated with an international youth sporting event&#x02014;Pennsylvania, Michigan and Texas, August&#x02013;September 2007. MMWR Morb Mortal Wkly Rep. 2008;57:169&#x02013;73.</mixed-citation></ref><ref id="CR103"><label>103.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Outbreak of measles &#x02013; San Diego, California, January&#x02013;February 2008. MMWR Morb Mortal Wkly Rep. 2008;57:203&#x02013;6.</mixed-citation></ref><ref id="CR104"><label>104.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Measles&#x02014;United States, January 1&#x02013;April 25, 2008. MMWR Morb Mortal Wkly Rep. 2008;57:1&#x02013;4.</mixed-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>AM</given-names></name><name><surname>Gust</surname><given-names>DA</given-names></name></person-group><article-title>Measles outbreak associated with a church congregation: a study of immunization attitudes of congregation members</article-title><source>Public Health Rep</source><year>2008</year><volume>123</volume><fpage>126</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1177/003335490812300205</pub-id><?supplied-pmid 18457065?><pub-id pub-id-type="pmid">18457065</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugarman</surname><given-names>DE</given-names></name><name><surname>Barskey</surname><given-names>AE</given-names></name><name><surname>Delea</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated</article-title><source>Pediatrics</source><year>2010</year><volume>125</volume><fpage>747</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1542/peds.2009-1653</pub-id><pub-id pub-id-type="pmid">20308208</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Notes from the field: measles outbreak among members of a religious community &#x02013; Brooklyn, New York, March &#x02013; June 2013. MMWR Morb Mortal Wkly Rep. 2013;62:752&#x02013;3.</mixed-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zipprich</surname><given-names>J</given-names></name><name><surname>Winter</surname><given-names>K</given-names></name><name><surname>Hacker</surname><given-names>J</given-names></name><etal/></person-group><article-title>Measles outbreak-California, December 2014-February 2015</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2015</year><volume>64</volume><fpage>153</fpage><lpage>4</lpage><?supplied-pmid 25695321?><pub-id pub-id-type="pmid">25695321</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>RD</given-names></name><name><surname>Goetz</surname><given-names>MB</given-names></name></person-group><article-title>Clinical and laboratory features of measles in hospitalized adults</article-title><source>Am J Med</source><year>1993</year><volume>95</volume><fpage>377</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/0002-9343(93)90306-A</pub-id><?supplied-pmid 8213869?><pub-id pub-id-type="pmid">8213869</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peltola</surname><given-names>H</given-names></name><name><surname>Kulkarni</surname><given-names>PS</given-names></name><name><surname>Kapre</surname><given-names>SV</given-names></name><etal/></person-group><article-title>Mumps outbreak in Canada and the United States: time for new thinking on mumps vaccines</article-title><source>Clin Infect Dis</source><year>2007</year><volume>45</volume><fpage>459</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1086/520028</pub-id><?supplied-pmid 17638194?><pub-id pub-id-type="pmid">17638194</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Update: multistate outbreak of mumps-United States, January 1&#x02013;May 2, 2006. MMWR Morb Mortal Wkly Rep. 2006;55:1.</mixed-citation></ref><ref id="CR112"><label>112.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Update: multistate outbreak of mumps-United States, January 1&#x02013;May 2, 2006. MMWR Morb Mortal Wkly Rep. 2006;55:559.</mixed-citation></ref><ref id="CR113"><label>113.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Update: mumps activity&#x02014;United States, January 1&#x02013;October 7, 2006. MMWR Morb Mortal Wkly Rep. 2006;55:1152.</mixed-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dayan</surname><given-names>GH</given-names></name><name><surname>Quinlisk</surname><given-names>P</given-names></name><name><surname>Parker</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Recent resurgence of mumps in the United States</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>1580</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0706589</pub-id><?supplied-pmid 18403766?><pub-id pub-id-type="pmid">18403766</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>DW</given-names></name><name><surname>Nam</surname><given-names>M-H</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>4665</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2007.04.013</pub-id><?supplied-pmid 17498856?><pub-id pub-id-type="pmid">17498856</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>F</given-names></name><name><surname>Hassan</surname><given-names>J</given-names></name><name><surname>Irwin</surname><given-names>F</given-names></name><etal/></person-group><article-title>Epidemiologic and diagnostic evaluation of a recent mumps outbreak using oral fluid samples</article-title><source>J Clin Virol</source><year>2008</year><volume>41</volume><fpage>134</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2007.10.009</pub-id><?supplied-pmid 18354822?><pub-id pub-id-type="pmid">18354822</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanley</surname><given-names>JD</given-names></name></person-group><article-title>The resurgence of mumps in young adults and adolescents</article-title><source>Cleve Clin J Med</source><year>2007</year><volume>74</volume><issue>42&#x02013;44</issue><fpage>47</fpage><lpage>8</lpage></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitsko</surname><given-names>RH</given-names></name><name><surname>Cortese</surname><given-names>MM</given-names></name><name><surname>Dayan</surname><given-names>GH</given-names></name><etal/></person-group><article-title>Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage</article-title><source>J Clin Microbiol</source><year>2008</year><volume>46</volume><fpage>1101</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1128/JCM.01803-07</pub-id><?supplied-pmid 18184850?><pub-id pub-id-type="pmid">18184850</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Parry</surname><given-names>R</given-names></name><etal/></person-group><article-title>Real-time PCR and its application to mumps rapid diagnosis</article-title><source>J Med Virol</source><year>2007</year><volume>79</volume><fpage>1761</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/jmv.20880</pub-id><?supplied-pmid 17854025?><pub-id pub-id-type="pmid">17854025</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>SR</given-names></name><name><surname>Ortin</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Revaccination with measles, tetanus, poliovirus, <italic>Haemophilus influenzae</italic> b, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation</article-title><source>Clin Infect Dis</source><year>2007</year><volume>44</volume><fpage>625</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1086/511641</pub-id><?supplied-pmid 17278051?><pub-id pub-id-type="pmid">17278051</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep. 2000;49(RR10):1&#x02013;125.</mixed-citation></ref><ref id="CR122"><label>122.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Updated norovirus outbreak management and disease prevention guidelines. MMWR Morb Mort Wkly Rep. 2011;60(RR03):1&#x02013;15.</mixed-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mead</surname><given-names>PS</given-names></name><name><surname>Slutsker</surname><given-names>L</given-names></name><name><surname>Dietz</surname><given-names>V</given-names></name><etal/></person-group><article-title>Food-related illness and death in the United States</article-title><source>Emerg Infect Dis</source><year>1999</year><volume>5</volume><fpage>607</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.3201/eid0505.990502</pub-id><?supplied-pmid 10511517?><pub-id pub-id-type="pmid">10511517</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>JA</given-names></name><name><surname>Hellard</surname><given-names>ME</given-names></name><name><surname>Sinclair</surname><given-names>MI</given-names></name><etal/></person-group><article-title>Incidence and characteristics of endemic Norwalk-like virus-associated gastroenteritis</article-title><source>J Med Virol</source><year>2003</year><volume>69</volume><fpage>568</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1002/jmv.10346</pub-id><?supplied-pmid 12601766?><pub-id pub-id-type="pmid">12601766</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopman</surname><given-names>BA</given-names></name><name><surname>Adak</surname><given-names>GK</given-names></name><name><surname>Reacher</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Two epidemiologic patterns of norovirus outbreaks: surveillance in England and Wales, 1992&#x02013;2000</article-title><source>Emerg Infect Dis</source><year>2003</year><volume>9</volume><fpage>71</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.3201/eid0901.020175</pub-id><?supplied-pmid 12533284?><pub-id pub-id-type="pmid">12533284</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>ET-V</given-names></name><name><surname>Bull</surname><given-names>RA</given-names></name><name><surname>Kim</surname><given-names>M-J</given-names></name><etal/></person-group><article-title>Norovirus excretion in an aged-care setting</article-title><source>J Clin Microbiol</source><year>2008</year><volume>46</volume><fpage>2119</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1128/JCM.02198-07</pub-id><?supplied-pmid 18417655?><pub-id pub-id-type="pmid">18417655</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makary</surname><given-names>P</given-names></name><name><surname>Maunula</surname><given-names>L</given-names></name><name><surname>Niskanen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Multiple norovirus outbreaks among workplace canteen users in Finland, July 2006</article-title><source>Epidemiol Infect</source><year>2009</year><volume>137</volume><fpage>402</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1017/S0950268808000605</pub-id><?supplied-pmid 18387215?><pub-id pub-id-type="pmid">18387215</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S-Y</given-names></name><name><surname>Tsai</surname><given-names>C-N</given-names></name><name><surname>Lai</surname><given-names>M-W</given-names></name><etal/></person-group><article-title>Norovirus infection as a cause of diarrhea-associated benign infantile seizures</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><fpage>849</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1086/597256</pub-id><?supplied-pmid 19239351?><pub-id pub-id-type="pmid">19239351</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>MM</given-names></name><name><surname>Hall</surname><given-names>AJ</given-names></name><name><surname>Vinje</surname><given-names>J</given-names></name><etal/></person-group><article-title>Noroviruses: a comprehensive review</article-title><source>J Clin Virol</source><year>2009</year><volume>44</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2008.10.009</pub-id><?supplied-pmid 19084472?><pub-id pub-id-type="pmid">19084472</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>DE</given-names></name><name><surname>Kohn</surname><given-names>MA</given-names></name><name><surname>Farley</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Multistate outbreaks of acute gastroenteritis traced to fecal-contaminated oysters harvested in Louisiana</article-title><source>J Infect Dis</source><year>2000</year><volume>181</volume><issue>Suppl 2</issue><fpage>S381</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1086/315581</pub-id><?supplied-pmid 10804152?><pub-id pub-id-type="pmid">10804152</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>AD</given-names></name><name><surname>Garrett</surname><given-names>VD</given-names></name><name><surname>Sobel</surname><given-names>J</given-names></name><etal/></person-group><article-title>Multistate outbreak of Norwalk-like virus gastroenteritis associated with a common caterer</article-title><source>Am J Epidemiol</source><year>2001</year><volume>154</volume><fpage>1013</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1093/aje/154.11.1013</pub-id><?supplied-pmid 11724717?><pub-id pub-id-type="pmid">11724717</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Norwalk-like virus associated gastroenteritis in a large, high-density encampment&#x02014;Virginia, July 2001. JAMA. 2001;288:1711&#x02013;3.</mixed-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>KM</given-names></name><name><surname>Moe</surname><given-names>CL</given-names></name><name><surname>Southwick</surname><given-names>KL</given-names></name><etal/></person-group><article-title>Transmission of Norwalk virus during a football game</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><fpage>1223</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1056/NEJM200010263431704</pub-id><?supplied-pmid 11071673?><pub-id pub-id-type="pmid">11071673</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuritsky</surname><given-names>JN</given-names></name><name><surname>Osterholm</surname><given-names>MT</given-names></name><name><surname>Greenberg</surname><given-names>HB</given-names></name><etal/></person-group><article-title>Norwalk gastroenteritis: a community outbreak associated with bakery product consumption</article-title><source>Ann Intern Med</source><year>1984</year><volume>100</volume><fpage>519</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-100-4-519</pub-id><?supplied-pmid 6322631?><pub-id pub-id-type="pmid">6322631</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>SM</given-names></name><name><surname>Adak</surname><given-names>GK</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>General outbreaks of infectious intestinal disease linked with salad vegetables and fruit, England and Wales, 1992&#x02013;2000</article-title><source>Commun Dis Public Health</source><year>2002</year><volume>5</volume><fpage>101</fpage><lpage>5</lpage><?supplied-pmid 12166293?><pub-id pub-id-type="pmid">12166293</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>HW</given-names></name><name><surname>Braun</surname><given-names>MM</given-names></name><name><surname>Glass</surname><given-names>RI</given-names></name><etal/></person-group><article-title>Waterborne outbreak of Norwalk virus gastroenteritis at a southwest US resort: role of geological formations in contamination of well water</article-title><source>Lancet</source><year>1991</year><volume>337</volume><fpage>1200</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/0140-6736(91)92868-3</pub-id><?supplied-pmid 1673747?><pub-id pub-id-type="pmid">1673747</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>RC</given-names></name><name><surname>Murphy</surname><given-names>FD</given-names></name><name><surname>Greenberg</surname><given-names>HB</given-names></name><etal/></person-group><article-title>Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission</article-title><source>Am J Epidemiol</source><year>1982</year><volume>115</volume><fpage>163</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a113287</pub-id><?supplied-pmid 6277184?><pub-id pub-id-type="pmid">6277184</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotz</surname><given-names>H</given-names></name><name><surname>Ekdahl</surname><given-names>K</given-names></name><name><surname>Lindback</surname><given-names>J</given-names></name><etal/></person-group><article-title>Clinical spectrum and transmission characteristics of infection with Norwalk-like virus: findings from a large community outbreak in Sweden</article-title><source>Clin Infect Dis</source><year>2001</year><volume>33</volume><fpage>622</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1086/322608</pub-id><?supplied-pmid 11477530?><pub-id pub-id-type="pmid">11477530</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>J</given-names></name><name><surname>Bell</surname><given-names>D</given-names></name><name><surname>Simmons</surname><given-names>GC</given-names></name><etal/></person-group><article-title>Gastroenteritis outbreak caused by waterborne norovirus at a New Zealand ski resort</article-title><source>Appl Environ Microbiol</source><year>2007</year><volume>73</volume><fpage>7853</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1128/AEM.00718-07</pub-id><?supplied-pmid 17965205?><pub-id pub-id-type="pmid">17965205</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>KY</given-names></name><name><surname>Belliot</surname><given-names>G</given-names></name><name><surname>Taylor</surname><given-names>JL</given-names></name><etal/></person-group><article-title>A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly</article-title><source>Clin Infect Dis</source><year>2001</year><volume>33</volume><fpage>622</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1086/322608</pub-id><pub-id pub-id-type="pmid">11477530</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>K</given-names></name></person-group><article-title>Norwalk-like virus attacks troops in Afghanistan</article-title><source>Lancet Infect Dis</source><year>2002</year><volume>2</volume><fpage>391</fpage><pub-id pub-id-type="doi">10.1016/S1473-3099(02)00337-7</pub-id><?supplied-pmid 12127346?><pub-id pub-id-type="pmid">12127346</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattner</surname><given-names>F</given-names></name><name><surname>Sohr</surname><given-names>D</given-names></name><name><surname>Heim</surname><given-names>A</given-names></name><etal/></person-group><article-title>Risk groups for clinical complications of norovirus infections: an outbreak investigation</article-title><source>Clin Microbiol Infect</source><year>2006</year><volume>12</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2005.01299.x</pub-id><?supplied-pmid 16460549?><pub-id pub-id-type="pmid">16460549</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Said</surname><given-names>MA</given-names></name><name><surname>Perl</surname><given-names>TM</given-names></name><name><surname>Sears</surname><given-names>CL</given-names></name></person-group><article-title>Gastrointestinal flu: norovirus in health care and long-term care facilities</article-title><source>Clin Infect Dis</source><year>2008</year><volume>47</volume><fpage>1202</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1086/592299</pub-id><?supplied-pmid 18808354?><pub-id pub-id-type="pmid">18808354</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname><given-names>BA</given-names></name><name><surname>Thekkel</surname><given-names>V</given-names></name><name><surname>Eisenstein</surname><given-names>L</given-names></name></person-group><article-title>Community-acquired norovirus diarrhoea outbreak mimicking a community-acquired <italic>C. difficile</italic> diarrhoea outbreak</article-title><source>J Hosp Infect</source><year>2008</year><volume>70</volume><fpage>98</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2008.06.001</pub-id><?supplied-pmid 18621444?><pub-id pub-id-type="pmid">18621444</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Norovirus outbreak associated with a natural lake used for recreation &#x02013; Oregon, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:485&#x02013;90.</mixed-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>JP</given-names></name><name><surname>Edmunds</surname><given-names>J</given-names></name><name><surname>Pebody</surname><given-names>R</given-names></name><etal/></person-group><article-title>Deaths from norovirus among the elderly, England and Wales</article-title><source>Emerg Infect Dis</source><year>2008</year><volume>14</volume><fpage>1546</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.3201/eid1410.080188</pub-id><?supplied-pmid 18826817?><pub-id pub-id-type="pmid">18826817</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhoef</surname><given-names>LPB</given-names></name><name><surname>Kroneman</surname><given-names>A</given-names></name><name><surname>van Duynhoven</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Selection tool for foodborne norovirus outbreaks</article-title><source>Emerg Infect Dis</source><year>2009</year><volume>15</volume><fpage>31</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.3201/eid1501.080673</pub-id><?supplied-pmid 19116046?><pub-id pub-id-type="pmid">19116046</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>MM</given-names></name><name><surname>Widdowson</surname><given-names>M-A</given-names></name><name><surname>Glass</surname><given-names>RI</given-names></name><etal/></person-group><article-title>Systematic literature review of role of noroviruses in sporadic gastroenteritis</article-title><source>Emerg Infect Dis</source><year>2008</year><volume>14</volume><fpage>1224</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.3201/eid1408.071114</pub-id><?supplied-pmid 18680645?><pub-id pub-id-type="pmid">18680645</pub-id></element-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Adams</surname><given-names>O</given-names></name><name><surname>Laws</surname><given-names>H-J</given-names></name><etal/></person-group><article-title>Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus</article-title><source>J Med Virol</source><year>2008</year><volume>80</volume><fpage>1461</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/jmv.21217</pub-id><?supplied-pmid 18551595?><pub-id pub-id-type="pmid">18551595</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roos-Weil</surname><given-names>D</given-names></name><name><surname>Ambert-Balay</surname><given-names>K</given-names></name><name><surname>Lanternier</surname><given-names>F</given-names></name><etal/></person-group><article-title>Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea</article-title><source>Transplantation</source><year>2011</year><volume>92</volume><fpage>61</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/TP.0b013e31821c9392</pub-id><?supplied-pmid 21555974?><pub-id pub-id-type="pmid">21555974</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robles</surname><given-names>JDR</given-names></name><name><surname>Cheuk</surname><given-names>DKL</given-names></name><name><surname>Ha</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Norovirus infection in pediatric hematopoietic stem cell transplantation recipients: incidence, risk factors, and outcome</article-title><source>Biol Blood Marrow Transplant</source><year>2012</year><volume>18</volume><fpage>1883</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.bbmt.2012.07.005</pub-id><?supplied-pmid 22796532?><pub-id pub-id-type="pmid">22796532</pub-id></element-citation></ref><ref id="CR152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>S</given-names></name><name><surname>Vergoulidou</surname><given-names>M</given-names></name><name><surname>Schreier</surname><given-names>E</given-names></name><etal/></person-group><article-title>Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation</article-title><source>Blood</source><year>2011</year><volume>117</volume><fpage>5850</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-12-325886</pub-id><?supplied-pmid 21487110?><pub-id pub-id-type="pmid">21487110</pub-id></element-citation></ref><ref id="CR153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreier</surname><given-names>E</given-names></name><name><surname>Doring</surname><given-names>F</given-names></name><name><surname>Kunkel</surname><given-names>U</given-names></name></person-group><article-title>Molecular epidemiology of outbreaks of gastroenteritis associated with small round structured viruses in Germany in 1997/98</article-title><source>Arch Virol</source><year>2000</year><volume>145</volume><fpage>443</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1007/s007050050038</pub-id><?supplied-pmid 10795514?><pub-id pub-id-type="pmid">10795514</pub-id></element-citation></ref><ref id="CR154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kauffman</surname><given-names>SS</given-names></name><name><surname>Cahtterjee</surname><given-names>NK</given-names></name><name><surname>Fuschino</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Calicivirus enteritis in an intestinal transplant recipient</article-title><source>Am J Transplant</source><year>2003</year><volume>3</volume><fpage>764</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1034/j.1600-6143.2003.00112.x</pub-id><pub-id pub-id-type="pmid">12780570</pub-id></element-citation></ref><ref id="CR155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eid</surname><given-names>AJ</given-names></name></person-group><article-title>Posfay-Barbe KM and the AST Infectious Diseases Community of Practice</article-title><source>Am J Transplant</source><year>2009</year><volume>9</volume><issue>Suppl 4</issue><fpage>S147</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2009.02905.x</pub-id><?supplied-pmid 20070674?><pub-id pub-id-type="pmid">20070674</pub-id></element-citation></ref><ref id="CR156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonvicini</surname><given-names>F</given-names></name><name><surname>Marinacci</surname><given-names>G</given-names></name><name><surname>Pajno</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman</article-title><source>Clin Infect Dis</source><year>2008</year><volume>47</volume><fpage>384</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1086/589863</pub-id></element-citation></ref><ref id="CR157"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douvoyiannis</surname><given-names>M</given-names></name><name><surname>Litman</surname><given-names>N</given-names></name><name><surname>Goldman</surname><given-names>DL</given-names></name></person-group><article-title>Neurologic manifestations associated with parvovirus B19 infection</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><fpage>1713</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1086/599042</pub-id><?supplied-pmid 19441978?><pub-id pub-id-type="pmid">19441978</pub-id></element-citation></ref><ref id="CR158"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klumpen</surname><given-names>H-J</given-names></name><name><surname>Petersen</surname><given-names>EJ</given-names></name><name><surname>Verdonck</surname><given-names>LF</given-names></name></person-group><article-title>Severe multiorgan failure after parvovirus B19 infection in an allogeneic stem cell transplant recipient</article-title><source>Bone Marrow Transplant</source><year>2004</year><volume>34</volume><fpage>469</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1038/sj.bmt.1704612</pub-id><?supplied-pmid 15258560?><pub-id pub-id-type="pmid">15258560</pub-id></element-citation></ref><ref id="CR159"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurenz</surname><given-names>M</given-names></name><name><surname>Winkelmann</surname><given-names>B</given-names></name><name><surname>Roigas</surname><given-names>J</given-names></name><etal/></person-group><article-title>Severe parvovirus B19 encephalitis after renal transplantation</article-title><source>Pediatr Transplant</source><year>2006</year><volume>10</volume><fpage>978</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1111/j.1399-3046.2006.00599.x</pub-id><?supplied-pmid 17096771?><pub-id pub-id-type="pmid">17096771</pub-id></element-citation></ref><ref id="CR160"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JB</given-names></name><name><surname>Kim</surname><given-names>D-J</given-names></name><name><surname>Woo</surname><given-names>S-Y</given-names></name><etal/></person-group><article-title>Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients &#x02013; a prospective study</article-title><source>Transpl Int</source><year>2009</year><volume>22</volume><fpage>455</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1111/j.1432-2277.2008.00818.x</pub-id><?supplied-pmid 19144091?><pub-id pub-id-type="pmid">19144091</pub-id></element-citation></ref><ref id="CR161"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yango</surname><given-names>A</given-names></name><name><surname>Morrissey</surname><given-names>P</given-names></name><name><surname>Gohh</surname><given-names>R</given-names></name><etal/></person-group><article-title>Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction</article-title><source>Transpl Infect Dis</source><year>2002</year><volume>4</volume><fpage>163</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1034/j.1399-3062.2002.01007.x</pub-id><?supplied-pmid 12421463?><pub-id pub-id-type="pmid">12421463</pub-id></element-citation></ref><ref id="CR162"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasak-Szullkowska</surname><given-names>E</given-names></name><name><surname>Grabarczyk</surname><given-names>P</given-names></name><name><surname>Rzepecki</surname><given-names>P</given-names></name></person-group><article-title>Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation</article-title><source>Transpl Infect Dis</source><year>2008</year><volume>10</volume><fpage>201</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1111/j.1399-3062.2007.00266.x</pub-id><pub-id pub-id-type="pmid">17631000</pub-id></element-citation></ref><ref id="CR163"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muetherig</surname><given-names>A</given-names></name><name><surname>Christopeit</surname><given-names>M</given-names></name><name><surname>Muller</surname><given-names>LP</given-names></name><etal/></person-group><article-title>Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients</article-title><source>Bone Marrow Transplant</source><year>2007</year><volume>39</volume><fpage>315</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/sj.bmt.1705589</pub-id><?supplied-pmid 17311086?><pub-id pub-id-type="pmid">17311086</pub-id></element-citation></ref><ref id="CR164"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plentz</surname><given-names>A</given-names></name><name><surname>Hahn</surname><given-names>J</given-names></name><name><surname>Holler</surname><given-names>E</given-names></name><etal/></person-group><article-title>Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation</article-title><source>J Clin Virol</source><year>2004</year><volume>31</volume><fpage>16</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2004.05.015</pub-id><?supplied-pmid 15288608?><pub-id pub-id-type="pmid">15288608</pub-id></element-citation></ref><ref id="CR165"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renoult</surname><given-names>E</given-names></name><name><surname>Bachelet</surname><given-names>C</given-names></name><name><surname>Krier-Coudert</surname><given-names>M-J</given-names></name><etal/></person-group><article-title>Recurrent anemia in kidney transplant recipients with parvovirus B19 infection</article-title><source>Transplant Proc</source><year>2006</year><volume>38</volume><fpage>2321</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2006.06.116</pub-id><?supplied-pmid 16980079?><pub-id pub-id-type="pmid">16980079</pub-id></element-citation></ref><ref id="CR166"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckhoff</surname><given-names>A</given-names></name><name><surname>Steffen</surname><given-names>I</given-names></name><name><surname>Sandoz</surname><given-names>P</given-names></name><etal/></person-group><article-title>Relapsing severe anaemia due to primary parvovirus B19 infection after renal transplantation: a case report and review of the literature</article-title><source>Nephrol Dial Transplant</source><year>2007</year><volume>22</volume><fpage>3660</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfm531</pub-id><?supplied-pmid 17890751?><pub-id pub-id-type="pmid">17890751</pub-id></element-citation></ref><ref id="CR167"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardalan</surname><given-names>MR</given-names></name><name><surname>Shoja</surname><given-names>MM</given-names></name><name><surname>Tubbs</surname><given-names>RS</given-names></name><name><surname>Jayne</surname><given-names>D</given-names></name></person-group><article-title>Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis</article-title><source>Exp Clin Transplant</source><year>2008</year><volume>6</volume><fpage>137</fpage><lpage>43</lpage><?supplied-pmid 18816241?><pub-id pub-id-type="pmid">18816241</pub-id></element-citation></ref><ref id="CR168"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardalan</surname><given-names>MR</given-names></name><name><surname>Shoja</surname><given-names>MM</given-names></name><name><surname>Tubbs</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus B19 infection</article-title><source>Am J Transplant</source><year>2008</year><volume>8</volume><fpage>1340</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2008.02244.x</pub-id><?supplied-pmid 18522549?><pub-id pub-id-type="pmid">18522549</pub-id></element-citation></ref><ref id="CR169"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barzon</surname><given-names>L</given-names></name><name><surname>Murer</surname><given-names>L</given-names></name><name><surname>Pacenti</surname><given-names>M</given-names></name><etal/></person-group><article-title>Investigation of intrarenal infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury</article-title><source>J Infect Dis</source><year>2009</year><volume>199</volume><fpage>372</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1086/596053</pub-id><?supplied-pmid 19099488?><pub-id pub-id-type="pmid">19099488</pub-id></element-citation></ref><ref id="CR170"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breinholt</surname><given-names>JP</given-names></name><name><surname>Moulik</surname><given-names>M</given-names></name><name><surname>Dreyer</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients</article-title><source>J Heart Lung Transplant</source><year>2010</year><volume>29</volume><fpage>739</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.healun.2010.03.003</pub-id><?supplied-pmid 20456978?><pub-id pub-id-type="pmid">20456978</pub-id></element-citation></ref><ref id="CR171"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allander</surname><given-names>T</given-names></name><name><surname>Andreasson</surname><given-names>K</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><etal/></person-group><article-title>Identification of a third human polyomavirus</article-title><source>J Virol</source><year>2007</year><volume>81</volume><fpage>4130</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1128/JVI.00028-07</pub-id><?supplied-pmid 17287263?><pub-id pub-id-type="pmid">17287263</pub-id></element-citation></ref><ref id="CR172"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaynor</surname><given-names>AM</given-names></name><name><surname>Missen</surname><given-names>MD</given-names></name><name><surname>Whiley</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Identification of a novel polyomavirus from patients with acute respiratory tract infections</article-title><source>PLoS Pathog</source><year>2007</year><volume>3</volume><fpage>595</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1371/journal.ppat.0030064</pub-id></element-citation></ref><ref id="CR173"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharp</surname><given-names>CP</given-names></name><name><surname>Norja</surname><given-names>P</given-names></name><name><surname>Anthony</surname><given-names>I</given-names></name><name><surname>Bell</surname><given-names>JE</given-names></name><name><surname>Simmonds</surname><given-names>P</given-names></name></person-group><article-title>Reactivation and mutation of newly discovered WU, KI and Merkel Cell carcinoma polyomaviruses in immunosuppressed individuals</article-title><source>J Infect Dis</source><year>2009</year><volume>199</volume><fpage>398</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1086/596062</pub-id><?supplied-pmid 19090778?><pub-id pub-id-type="pmid">19090778</pub-id></element-citation></ref><ref id="CR174"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mourez</surname><given-names>T</given-names></name><name><surname>Bergeron</surname><given-names>A</given-names></name><name><surname>Ribaud</surname><given-names>P</given-names></name><etal/></person-group><article-title>Polyomaviruses KI and WU in immunocompromised patients with respiratory disease</article-title><source>Emerg Infect Dis</source><year>2009</year><volume>15</volume><fpage>107</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.3201/eid1501.080758</pub-id><?supplied-pmid 19116066?><pub-id pub-id-type="pmid">19116066</pub-id></element-citation></ref><ref id="CR175"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dibiaggi</surname><given-names>M</given-names></name><name><surname>Canducci</surname><given-names>F</given-names></name><name><surname>Brerra</surname><given-names>R</given-names></name><etal/></person-group><article-title>Molecular epidemiology of KI and WU polyomaviruses in infants with acute respiratory disease and in adult hematopoietic stem cell transplant recipients</article-title><source>J Med Virol</source><year>2010</year><volume>82</volume><fpage>153</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1002/jmv.21659</pub-id><pub-id pub-id-type="pmid">19950241</pub-id></element-citation></ref><ref id="CR176"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penn</surname><given-names>I</given-names></name><name><surname>First</surname><given-names>MR</given-names></name></person-group><article-title>Merkel&#x02019;s cell carcinoma in organ recipients: report of 41 cases</article-title><source>Transplantation</source><year>1999</year><volume>68</volume><fpage>1717</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1097/00007890-199912150-00015</pub-id><?supplied-pmid 10609948?><pub-id pub-id-type="pmid">10609948</pub-id></element-citation></ref><ref id="CR177"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stelzmueller</surname><given-names>I</given-names></name><name><surname>Wiesmayr</surname><given-names>S</given-names></name><name><surname>Swenson</surname><given-names>BR</given-names></name><etal/></person-group><article-title>Rotavirus enteritis in solid organ transplant recipients: an underestimated problem?</article-title><source>Transpl Infect Dis</source><year>2007</year><volume>9</volume><fpage>281</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1111/j.1399-3062.2007.00251.x</pub-id><?supplied-pmid 17605739?><pub-id pub-id-type="pmid">17605739</pub-id></element-citation></ref><ref id="CR178"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Metselaar</surname><given-names>HJ</given-names></name><name><surname>Sprengers</surname><given-names>D</given-names></name><etal/></person-group><article-title>Rotavirus in organ transplantation: drug-virus-host interactions</article-title><source>Am J Transplant</source><year>2015</year><volume>15</volume><fpage>585</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1111/ajt.13135</pub-id><?supplied-pmid 25693470?><pub-id pub-id-type="pmid">25693470</pub-id></element-citation></ref><ref id="CR179"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haber</surname><given-names>P</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Izurieta</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006 to September 25, 2007</article-title><source>Pediatrics</source><year>2008</year><volume>121</volume><fpage>1206</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1542/peds.2007-3793</pub-id><?supplied-pmid 18519491?><pub-id pub-id-type="pmid">18519491</pub-id></element-citation></ref><ref id="CR180"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyse</surname><given-names>JF</given-names></name><name><surname>Kuter</surname><given-names>BJ</given-names></name><name><surname>Dallas</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Evaluating the safety of a rotavirus vaccine: the REST of the story</article-title><source>Clin Trials</source><year>2008</year><volume>5</volume><fpage>131</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1177/1740774508090507</pub-id><?supplied-pmid 18375651?><pub-id pub-id-type="pmid">18375651</pub-id></element-citation></ref><ref id="CR181"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reisinger</surname><given-names>KS</given-names></name><name><surname>Block</surname><given-names>SL</given-names></name></person-group><article-title>Characteristics of an ideal rotavirus vaccine</article-title><source>Clin Pediatr</source><year>2008</year><volume>47</volume><fpage>555</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1177/0009922808314903</pub-id></element-citation></ref><ref id="CR182"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>LG</given-names></name><name><surname>Levin</surname><given-names>MJ</given-names></name><name><surname>Davies</surname><given-names>EG</given-names></name><etal/></person-group><article-title>2013 IDSA clinical guideline for vaccination of the immunocompromised host</article-title><source>Clin Infect Dis</source><year>2014</year><volume>58</volume><fpage>309</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1093/cid/cit816</pub-id><?supplied-pmid 24421306?><pub-id pub-id-type="pmid">24421306</pub-id></element-citation></ref><ref id="CR183"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gubler</surname><given-names>DJ</given-names></name></person-group><article-title>The continuing spread of West Nile virus in the western hemisphere</article-title><source>Clin Infect Dis</source><year>2007</year><volume>45</volume><fpage>1039</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1086/521911</pub-id><?supplied-pmid 17879923?><pub-id pub-id-type="pmid">17879923</pub-id></element-citation></ref><ref id="CR184"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Planitzer</surname><given-names>CB</given-names></name><name><surname>Modrof</surname><given-names>J</given-names></name><name><surname>Kreil</surname><given-names>TR</given-names></name></person-group><article-title>West Nile virus neutralization by US plasma-derived immunoglobulin products</article-title><source>J Infect Dis</source><year>2007</year><volume>196</volume><fpage>435</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1086/519392</pub-id><?supplied-pmid 17597458?><pub-id pub-id-type="pmid">17597458</pub-id></element-citation></ref><ref id="CR185"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nash</surname><given-names>D</given-names></name><name><surname>Mostashari</surname><given-names>F</given-names></name><name><surname>Fine</surname><given-names>A</given-names></name><etal/></person-group><article-title>The outbreak of West Nile virus infection in the New York City area in 1999</article-title><source>N Engl J Med</source><year>2001</year><volume>344</volume><fpage>1807</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1056/NEJM200106143442401</pub-id><?supplied-pmid 11407341?><pub-id pub-id-type="pmid">11407341</pub-id></element-citation></ref><ref id="CR186"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gea-Banacloche</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>RT</given-names></name><name><surname>Bagic</surname><given-names>A</given-names></name><etal/></person-group><article-title>West Nile virus: pathogenesis and therapeutic options</article-title><source>Ann Intern Med</source><year>2004</year><volume>140</volume><fpage>545</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-140-7-200404060-00015</pub-id><?supplied-pmid 15068983?><pub-id pub-id-type="pmid">15068983</pub-id></element-citation></ref><ref id="CR187"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>DD</given-names></name><name><surname>Gershman</surname><given-names>K</given-names></name><name><surname>LeBailly</surname><given-names>A</given-names></name><etal/></person-group><article-title>Characteristics of the rash associated with West Nile virus fever</article-title><source>Clin Infect Dis</source><year>2005</year><volume>41</volume><fpage>1204</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1086/444506</pub-id><?supplied-pmid 16163642?><pub-id pub-id-type="pmid">16163642</pub-id></element-citation></ref><ref id="CR188"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sejvar</surname><given-names>JJ</given-names></name></person-group><article-title>The long-tern outcomes of human West Nile virus infection</article-title><source>Clin Infect Dis</source><year>2007</year><volume>44</volume><fpage>1617</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1086/518281</pub-id><?supplied-pmid 17516407?><pub-id pub-id-type="pmid">17516407</pub-id></element-citation></ref><ref id="CR189"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>AV</given-names></name><name><surname>Sejvar</surname><given-names>JJ</given-names></name><name><surname>Pape</surname><given-names>J</given-names></name><etal/></person-group><article-title>West Nile virus disease: a descriptive study of 228 patents hospitalized in a 4-county region of Colorado in 2003</article-title><source>Clin Infect Dis</source><year>2006</year><volume>42</volume><fpage>1234</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1086/503038</pub-id><?supplied-pmid 16586381?><pub-id pub-id-type="pmid">16586381</pub-id></element-citation></ref><ref id="CR190"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sejvar</surname><given-names>JJ</given-names></name><name><surname>Haddad</surname><given-names>MB</given-names></name><name><surname>Tierney</surname><given-names>BC</given-names></name><etal/></person-group><article-title>Neurologic manifestations and outcome of West Nile virus infection</article-title><source>JAMA</source><year>2003</year><volume>290</volume><fpage>511</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1001/jama.290.4.511</pub-id><?supplied-pmid 12876094?><pub-id pub-id-type="pmid">12876094</pub-id></element-citation></ref><ref id="CR191"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paddock</surname><given-names>CD</given-names></name><name><surname>Nicholson</surname><given-names>WL</given-names></name><name><surname>Bhatnager</surname><given-names>J</given-names></name><etal/></person-group><article-title>Fatal hemorrhagic fever caused by West Nile virus in the United States</article-title><source>Clin Infect Dis</source><year>2006</year><volume>42</volume><fpage>1527</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1086/503841</pub-id><?supplied-pmid 16652309?><pub-id pub-id-type="pmid">16652309</pub-id></element-citation></ref><ref id="CR192"><label>192.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Possible dialysis-related West Nile virus transmission-Georgia, 2003. MMWR Morb Mortal Wkly Rep. 2004;53:738&#x02013;9.</mixed-citation></ref><ref id="CR193"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwamoto</surname><given-names>M</given-names></name><name><surname>Jernigan</surname><given-names>DB</given-names></name><name><surname>Guasch</surname><given-names>A</given-names></name><etal/></person-group><article-title>Transmission of West Nile virus from an organ donor to four transplant recipients</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>2196</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa022987</pub-id><?supplied-pmid 12773646?><pub-id pub-id-type="pmid">12773646</pub-id></element-citation></ref><ref id="CR194"><label>194.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Public health dispatch: West Nile virus infection in organ donor and transplant recipients-Georgia and Florida, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:790.</mixed-citation></ref><ref id="CR195"><label>195.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Update: investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion. MMWR Morb Mortal Wkly Rep. 2002;51:833&#x02013;6.</mixed-citation></ref><ref id="CR196"><label>196.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Public health dispatch: investigations of West Nile virus infections in recipients of blood transfusions. MMWR Morb Mortal Wkly Rep. 2002;51:973&#x02013;4.</mixed-citation></ref><ref id="CR197"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barshes</surname><given-names>NR</given-names></name><name><surname>Agee</surname><given-names>EE</given-names></name><name><surname>Zgabay</surname><given-names>T</given-names></name><etal/></person-group><article-title>West Nile virus encephalopathy following pancreatic islet transplantation</article-title><source>Am J Transplant</source><year>2006</year><volume>6</volume><fpage>3037</fpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2006.01564.x</pub-id><?supplied-pmid 17294529?><pub-id pub-id-type="pmid">17294529</pub-id></element-citation></ref><ref id="CR198"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepard</surname><given-names>JC</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Montgomery</surname><given-names>RA</given-names></name><etal/></person-group><article-title>West Nile virus encephalitis in a kidney transplant recipient</article-title><source>Am J Transplant</source><year>2004</year><volume>4</volume><fpage>830</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2004.00410.x</pub-id><pub-id pub-id-type="pmid">15084182</pub-id></element-citation></ref><ref id="CR199"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armali</surname><given-names>Z</given-names></name><name><surname>Ramadan</surname><given-names>R</given-names></name><name><surname>Chlebowski</surname><given-names>A</given-names></name><etal/></person-group><article-title>West Nile meningoencephalitis infection in a kidney transplant recipient</article-title><source>Transplant Proc</source><year>2003</year><volume>35</volume><fpage>2935</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2003.10.032</pub-id><?supplied-pmid 14697942?><pub-id pub-id-type="pmid">14697942</pub-id></element-citation></ref><ref id="CR200"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeSalvo</surname><given-names>D</given-names></name><name><surname>Roy-Chaudhury</surname><given-names>P</given-names></name><name><surname>Peddi</surname><given-names>R</given-names></name><etal/></person-group><article-title>West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death</article-title><source>Transplantation</source><year>2004</year><volume>77</volume><fpage>466</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/01.TP.0000101434.98873.CB</pub-id><?supplied-pmid 14966429?><pub-id pub-id-type="pmid">14966429</pub-id></element-citation></ref><ref id="CR201"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>D</given-names></name><name><surname>Prasad</surname><given-names>GV</given-names></name><name><surname>Zaltzman</surname><given-names>J</given-names></name><etal/></person-group><article-title>Community-acquired West Nile virus infection in solid-organ transplant recipients</article-title><source>Transplantation</source><year>2004</year><volume>77</volume><fpage>399</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1097/01.TP.0000101435.91619.31</pub-id><?supplied-pmid 14966414?><pub-id pub-id-type="pmid">14966414</pub-id></element-citation></ref><ref id="CR202"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinschmidt-DeMasters</surname><given-names>BK</given-names></name><name><surname>Marder</surname><given-names>BA</given-names></name><name><surname>Levi</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Naturally acquired West Nile virus encephalitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features</article-title><source>Arch Neurol</source><year>2004</year><volume>61</volume><fpage>1210</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1001/archneur.61.8.1210</pub-id><?supplied-pmid 15313837?><pub-id pub-id-type="pmid">15313837</pub-id></element-citation></ref><ref id="CR203"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penn</surname><given-names>RG</given-names></name><name><surname>Guarner</surname><given-names>J</given-names></name><name><surname>Sejvar</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Persistent neuroinvasive West Nile virus infection in an immunocompromised patient</article-title><source>Clin Infect Dis</source><year>2006</year><volume>42</volume><fpage>680</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1086/500216</pub-id><?supplied-pmid 16447115?><pub-id pub-id-type="pmid">16447115</pub-id></element-citation></ref><ref id="CR204"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>DS</given-names></name><name><surname>Jacobson</surname><given-names>KL</given-names></name><name><surname>Raad</surname><given-names>II</given-names></name><etal/></person-group><article-title>West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review</article-title><source>Clin Infect Dis</source><year>2003</year><volume>37</volume><fpage>1044</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1086/378278</pub-id><?supplied-pmid 14523768?><pub-id pub-id-type="pmid">14523768</pub-id></element-citation></ref><ref id="CR205"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiatt</surname><given-names>B</given-names></name><name><surname>Desjardin</surname><given-names>L</given-names></name><name><surname>Carter</surname><given-names>T</given-names></name><etal/></person-group><article-title>A fatal case of West Nile virus infection in a bone marrow transplant recipient</article-title><source>Clin Infect Dis</source><year>2003</year><volume>37</volume><fpage>e129</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1086/378891</pub-id><?supplied-pmid 14557983?><pub-id pub-id-type="pmid">14557983</pub-id></element-citation></ref><ref id="CR206"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tilley</surname><given-names>PA</given-names></name><name><surname>Fox</surname><given-names>JD</given-names></name><name><surname>Jayaraman</surname><given-names>GC</given-names></name><etal/></person-group><article-title>Nucleic acid testing for West Nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients</article-title><source>J Infect Dis</source><year>2006</year><volume>193</volume><fpage>1361</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1086/503577</pub-id><?supplied-pmid 16619182?><pub-id pub-id-type="pmid">16619182</pub-id></element-citation></ref><ref id="CR207"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname><given-names>I</given-names></name><name><surname>Briese</surname><given-names>T</given-names></name><name><surname>Fischer</surname><given-names>N</given-names></name><etal/></person-group><article-title>Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells</article-title><source>J Infect Dis</source><year>2000</year><volume>182</volume><fpage>1214</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1086/315847</pub-id><?supplied-pmid 10979920?><pub-id pub-id-type="pmid">10979920</pub-id></element-citation></ref><ref id="CR208"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamden</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>P</given-names></name><name><surname>Mendelson</surname><given-names>E</given-names></name><etal/></person-group><article-title>Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis</article-title><source>Transpl Infect Dis</source><year>2002</year><volume>4</volume><fpage>160</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1034/j.1399-3062.2002.01014.x</pub-id><pub-id pub-id-type="pmid">12421462</pub-id></element-citation></ref><ref id="CR209"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Nathan</surname><given-names>D</given-names></name><name><surname>Lustig</surname><given-names>S</given-names></name><name><surname>Tam</surname><given-names>G</given-names></name><etal/></person-group><article-title>Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice</article-title><source>J Infect Dis</source><year>2003</year><volume>188</volume><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1086/376870</pub-id><?supplied-pmid 12825165?><pub-id pub-id-type="pmid">12825165</pub-id></element-citation></ref><ref id="CR210"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makhoul</surname><given-names>B</given-names></name><name><surname>Braun</surname><given-names>E</given-names></name><name><surname>Herskovitz</surname><given-names>M</given-names></name><etal/></person-group><article-title>Hyperimmune gammaglobulin for the treatment of West Nile Virus encephalitis</article-title><source>Isr Med Assoc J</source><year>2009</year><volume>11</volume><fpage>151</fpage><lpage>3</lpage><?supplied-pmid 19544704?><pub-id pub-id-type="pmid">19544704</pub-id></element-citation></ref><ref id="CR211"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>PJ</given-names></name><name><surname>Konewko</surname><given-names>P</given-names></name><name><surname>Wold</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Long-term clinical and neuropsychological outcomes of West Nile virus infection</article-title><source>Clin Infect Dis</source><year>2006</year><volume>43</volume><fpage>723</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1086/506939</pub-id><?supplied-pmid 16912946?><pub-id pub-id-type="pmid">16912946</pub-id></element-citation></ref><ref id="CR212"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morelli</surname><given-names>MC</given-names></name><name><surname>Sambri</surname><given-names>V</given-names></name><name><surname>Grazi</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile Virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically</article-title><source>Clin Infect Dis</source><year>2010</year><volume>51</volume><fpage>e34</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1086/655146</pub-id><?supplied-pmid 20597692?><pub-id pub-id-type="pmid">20597692</pub-id></element-citation></ref><ref id="CR213"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>JE</given-names></name><name><surname>Pierson</surname><given-names>TC</given-names></name><name><surname>Hubka</surname><given-names>S</given-names></name><etal/></person-group><article-title>A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase I clinical trial</article-title><source>J Infect Dis</source><year>2007</year><volume>196</volume><fpage>1732</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1086/523650</pub-id><?supplied-pmid 18190252?><pub-id pub-id-type="pmid">18190252</pub-id></element-citation></ref><ref id="CR214"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funk</surname><given-names>GA</given-names></name><name><surname>Gosert</surname><given-names>R</given-names></name><name><surname>Hirsch</surname><given-names>HH</given-names></name></person-group><article-title>Viral dynamics in transplant patients: implications for disease</article-title><source>Lancet Infect Dis</source><year>2007</year><volume>7</volume><fpage>460</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(07)70159-7</pub-id><?supplied-pmid 17597570?><pub-id pub-id-type="pmid">17597570</pub-id></element-citation></ref><ref id="CR215"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wada</surname><given-names>K</given-names></name><name><surname>Kubota</surname><given-names>N</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay</article-title><source>J Clin Microbiol</source><year>2007</year><volume>45</volume><fpage>1426</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1128/JCM.01515-06</pub-id><?supplied-pmid 17376882?><pub-id pub-id-type="pmid">17376882</pub-id></element-citation></ref><ref id="CR216"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>TF</given-names></name><name><surname>Espy</surname><given-names>MJ</given-names></name><name><surname>Mandrekar</surname><given-names>J</given-names></name><etal/></person-group><article-title>Quantitative real-time polymerase chain reaction for evaluating DNAemia due to cytomegalovirus, Epstein-Barr virus, and BK virus in solid-organ transplant recipients</article-title><source>Clin Infect Dis</source><year>2007</year><volume>45</volume><fpage>1056</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1086/521909</pub-id><?supplied-pmid 17879925?><pub-id pub-id-type="pmid">17879925</pub-id></element-citation></ref><ref id="CR217"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberg</surname><given-names>A</given-names></name><name><surname>Zamora</surname><given-names>MR</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>The value of polymerase chain reaction for the diagnosis of viral respiratory tract infections on lung transplant recipients</article-title><source>J Clin Virol</source><year>2002</year><volume>25</volume><fpage>171</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/S1386-6532(02)00006-9</pub-id><?supplied-pmid 12367651?><pub-id pub-id-type="pmid">12367651</pub-id></element-citation></ref><ref id="CR218"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>D</given-names></name><name><surname>Erdman</surname><given-names>D</given-names></name><name><surname>Keshavjee</surname><given-names>S</given-names></name><etal/></person-group><article-title>Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant</article-title><source>Am J Transplant</source><year>2005</year><volume>5</volume><fpage>2031</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2005.00971.x</pub-id><?supplied-pmid 15996256?><pub-id pub-id-type="pmid">15996256</pub-id></element-citation></ref><ref id="CR219"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matar</surname><given-names>LD</given-names></name><name><surname>McAdams</surname><given-names>HP</given-names></name><name><surname>Palmer</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation</article-title><source>Radiology</source><year>1999</year><volume>213</volume><fpage>735</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1148/radiology.213.3.r99dc25735</pub-id><?supplied-pmid 10580947?><pub-id pub-id-type="pmid">10580947</pub-id></element-citation></ref></ref-list></back></article>